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1.  INTRODUCTION 
With few exceptions chronic and recurrent abdominal pain in children did not receive much 
attention in pediatric literature before the late 1950s.1 In 1958 Apley and Naishe published 
results from a population-based study of schoolchildren, and introduced the term “recurrent 
abdominal pain” (RAP) defined as at least three episodes of pain, severe enough to affect 
activities, over at least three months in the preceding year.2 Their definition soon became 
common in use and has been applied in clinical pediatric practice and research since then. 
However, with enhanced knowledge and understanding, both clinicians and researchers have 
recognised weaknesses with this term. RAP is a description, not a diagnosis. The definition is 
wide and general and includes heterogeneous disorders of abdominal pain, including those 
with organic and non-organic etiology. The vast majority of children and adolescents with 
RAP have non-organic abdominal pain.3 This heterogeneity of RAP has made research and 
treatment difficult. To make a distinction from organic disease, the term “functional 
gastrointestinal disorders” (FGIDs) has been established. These are chronic or recurrent 
gastrointestinal symptoms not explained by structural or biochemical abnormalities.4 The term 
“functional abdominal pain” (FAP) encompasses the pain related FGIDs.4   
 
As a physician working in a child- and adolescent outpatient clinic in secondary health care it 
was my impression that patients with psychosomatic problems were almost absent from our 
patient population and that very few patients were referred to us because of such problems. 
Inspired by my husband who did research on FAP in adults, I started asking my patients about 
presence of abdominal pain. I soon discovered that not only such symptoms, but also other 
unspecific somatic symptoms such as headache, back- and limb pain were common. In some 
patients the symptoms had a huge impact on their daily functioning. Exploring patient somatic 
symptoms in relation to their emotional and behavioral problems in parallel with going 
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through relevant literature stimulated a growing interest and fascination for children with FAP 
and the intricate communication between mind and body. I also realised that compared to 
abundant research on adults with FAP, far less research has been conducted in children and 
adolescents. However, children are not small adults, and results from research on the adult 
population may not be applicable to children.  
 
This thesis is based on two cohort studies that included a clinical sample of patients (4-15 
years) in general pediatric outpatient clinics and a population-based sample of adolescents (14 
years). The objective of the thesis was to study diagnostic classification and characteristics in 
children and adolescents with FAP, and further explore predictive- and prognostic factors of 
FAP.   
 
2. EMPIRICAL BACKGROUND  
2.1.  Prevalence and characteristics of children with FAP  
FAP is a common pain syndrome in children and adolescents. Previous studies indicate a 
prevalence between 10% and 15%. Some studies have reported two peaks in prevalence, first 
below five year of age, and then between 8 and 10 years,2, 5, 6 whereas another study found a 
progressive increase in prevalence in children below 12-15 year of age.7 It appears that girls 
have a higher prevalence of FAP than boys (female/male ratio 1.4:1) with a female 
predominance seeming to become evident around puberty.2, 5-7 FAP is also reported to account 
for 2–4% of all pediatric office visits.3, 8 
 
Children and adolescents with FAP experience a great variation with respect to quality, 
location, intensity, frequency and duration of abdominal pain symptoms.3, 4 They are further 
characterized by co-morbid (i.e., co-occurrence of) somatic (e.g., headache, back pain, limb 
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pain) and emotional symptoms (e.g., anxiety, depressive-) symptoms.9-13 However, the control 
groups in earlier studies are small and represent selected groups of children.9-12 Comparisons 
between pediatric patients with FAP and a representative sample of children in the general 
population have, to our knowledge, not been performed. Also the parents of children and 
adolescents with FAP are reported to have more somatic and emotional symptoms compared 
to healthy controls.9, 10, 13-15 Moreover, with few exceptions,16 children with FAP are found to 
report higher levels of negative life events compared to healthy individuals.17-19 However, 
level of negative life events is not found to discriminate between patients with FAP and other 
patients groups.3   
 
Some children with FAP experience substantial functional disability due to limitations in 
physical and psychosocial functioning reflected in restrictions in everyday activities, missed 
school days and physician visits.20-22 It is a common clinical experience that children 
reporting the same levels of abdominal pain symptoms (e.g., intensity and frequency) report 
very different levels in functional disability. Thus, other factors than merely the level of 
abdominal pain are likely to influence child pain and disability. Both emotional and somatic 
co-morbidity, parental health and responses to pain in their children, and negative life events 
are reported to negatively affect pain and disability in children with FAP.20, 23-26 
 
Patterns of disability and illness behavior can establish in childhood and may extend into 
adulthood in some people.21, 27  There is a need for increased understanding of the relation 
between pain and disability in children with FAP and factors such as child co-morbid 
symptoms, parental health and negative life events. Enhanced knowledge may be helpful in 
understanding factors important for development and maintenance of FAP in children. 
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2.2.  Conceptual model, causes and mechanisms 
Complex disorders such as FAP and the other FGIDs can not be explained by a simple 
biomedical disease-based model. A biopsychosocial model is far more comprehensive and 
seems to be the best prevailing model to conceptualize the pathogenesis and course of these 
disorders.28-30 According to this model, FAP in children can be achieved via different 
etiological pathways. The model also implies that there is an intricate and dynamic interplay 
between biological, psychological and environmental factors which may act as predisposing 
(e.g., genetics, early-life experiences), provoking (e.g., gut inflammation, psychosocial stress) 
and/or modifying factors (e.g., gender, gut flora, dietary components, personality, parental 
responses to child pain).31 Interactions between such factors may lead to disease onset and 
influence outcome.  
 
According to this model, FAP and the other FGIDs are more specifically believed to be 
caused by a dysregulation of the so called “brain-gut axis” which allows a bidirectional 
communication between emotional and cognitive centers of the central nervous system and 
the gastrointestinal tract.32, 33 Alterations at different levels of the local nervous system of the 
gut (i.e., the enteric nervous system), the autonomic and/or central nervous systems, or a 
disturbance of the dynamic interplay between these systems are thought to give rise to the 
brain-gut dysfunction.32, 33 However, the underlying pathophysiological mechanisms remain 
unclear. A variety of biological, psychological and environmental factors may interact via the 
brain-gut axis.32, 33 These interactions are thought to contribute to alterations in nerve 
receptors in the gut wall and the enteric nervous system, modulation of sensory transmission 
in the peripheral or central nervous system, and central pain processing (cortical perception 
and pain memories).30 The resulting changes in gastrointestinal sensitivity, motility and 
secretion are further believed to give rise abdominal pain symptoms.33 
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Observational studies with a cohort design may increase our understanding of predictors (i.e., 
variables associated with development of a disease/disorder) and prognostic factors (i.e., 
variables that predict patients to do better or worse) of FAP.  However, despite a growing 
body of research in this field, relatively few longitudinal studies have been conducted. The 
prospective design of the two studies included in this thesis is therefore of interest.  
 
The following sections give a brief overview of some possible factors that may be involved in 
the pathogenesis of FAP. Despite the categorization into predisposing, provoking and 
modifying factors, it is likely that some of the factors classify into several categories. 
  
2.2.1.  Predisposing factors 
The existence of more somatic and emotional symptoms in children with FAP and their 
parents when compared to healthy individuals is well known from previous cross-sectional 
studies,9, 12, 13, 15 although little longitudinal research exists. Of what there is, one population-
based study found parental anxiety and maternal somatic symptoms in the first year of a 
child’s life to predict FAP (i.e., RAP) in their offspring five years later.34 Another population-
based prospective study found somatic symptoms other than abdominal pain and psychosocial 
difficulties in children to predict new onset of chronic abdominal pain in adolescents.35 There 
is a need for longitudinal research to confirm these findings. The associations between 
parental and child symptoms appear to reflect both environmental and hereditary influences 
although the relative contribution of genetic and environmental factors is unclear (see section 
6.3.2. for more details).33, 36, 37 
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2.2.2.  Provoking factors 
Immunological alterations and low-grade inflammation in the gut, and changes in the central  
response to psychosocial stress have received increased attention in the field of 
gastroenterology.38 Based on research in adults with irritable bowel syndrome, the most 
common FAP, low-grade mucosal inflammation and immunological alterations in the gut wall 
(maybe as a result of alterations in gut flora and permeability) have been suggested to 
contribute to physiological dysfunction of the gut.38 Markers of gastrointestinal inflammation 
(e.g., calprotectin, lactoferrin and humant -defensin-2) may provide knowledge about the 
inflammatory mechanisms involved.39 
 
Calprotectin, an unspecific marker of inflammation, is a cytosolic protein found in 
inflammatory cells (primarily in neutrophil granulocytes, but also in monocytes and 
macrophages), and can be measured in feces, plasma and in other body fluids.40, 41 High fecal 
concentrations of calprotectin are found in patients with inflammatory bowel disease (i.e., 
ulcerative colitis and Crohn’s disease) and reflect flux of neutrophils into the gut wall, their 
turn over and migration into the gut lumen as a consequence of mucosal inflammation and 
tissue damage.40 When the present study was planned, several studies of children with FAP 
had reported no differences in fecal calprotectin concentrations when compared to healthy 
controls.42-45 To our knowledge, no study has investigated potential differences in fecal 
calprotectin concentrations between subgroups of children with FAP classified according the 
the pediatric Rome criteria.  
 
Psychosocial stress (e.g., low birth weight, sexual or physical abuse, parental emotional and 
physical distress/illness, serious illness in self or others) may be of importance for the central 
dysregulation of the brain-gut axis.33 This dysregulation is thought to involve alterations in 
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the autonomic nervous system and the hypothalamic-pituitary adrenal axis which are parts of 
the central stress response system.33, 46, 47 Long-term activation of the stress response system 
may have secondary, undesirable consequences including physiological dysfunction, 
increased vigilance toward innocuous visceral afferent information from the gut and maybe 
also other parts of the body, and emotional disturbance.46, 48  
 
2.2.3.  Modifying factors 
Several biopsychosocial factors appear to modify the gut immune activation and the stress-
response elicited. Alteration in the gut flora, dietary components (i.e., food allergens) and 
psychosocial stress may contribute to a prolonged stimulation of the immune and nervous 
system of the gut.31 Furthermore, a person’s interpretation of stress is influenced by severity 
and duration of the stressful events, but also by individual factors such as age, gender, illness, 
previous life experiences, personality and cognitive style (e.g., catastrophic thinking about 
pain).33, 48 The extent of fear and threats evoked influences the emotional reaction and the 
coping strategies used, which in turn is likely to be reflected in the physiological stress 
response elicited.48 Accordingly, a prospective study of pediatric patients with FAP showed 
that those who accepted pain and used accommodative coping strategies had better outcomes 
than those who felt most threatened by pain used passive coping strategies.49 
 
2.2.4. Outcome and prognostic factors 
Prospective studies have shown that abdominal pain persists in almost one third of the 
children with FAP.50 Moreover, former FAP patients do not only experience higher levels of 
abdominal pain, but also higher levels of emotional, other somatic symptoms and functional 
disability compared to healthy individuals.21, 51-54 However, previous cohort studies 
investigating prognosis of FAP have mainly been conducted in relatively small samples of 
 16 
referred children in specialist health care settings.50 Of the few long-term cohort studies, one 
birth cohort study reported that childhood FAP increased the likelihood of developing irritable 
bowel syndrome, the most common FAP, in adulthood.55 In contrast, another birth cohort 
study reported that FAP in childhood predicted psychiatric disorders and was modestly 
associated with other common somatic symptoms in adulthood.56  
 
Somatic and emotional symptoms in children and their parents, and negative life events are 
reported to be prognostic factors associated with pain persistence in some children, although 
relatively little prospective research exists23, 24, 26, 57 A short-term population-based study of 
children with FAP found child headache and a maternal history of anxiety measured when the 
children were six years old to be associated with sustained abdominal pain one year later.26 A 
five year prospective study of a clinical sample of pediatric patients with FAP in tertiary care 
found that somatic and emotional co-morbidity in the children were associated with persistent 
pain,57 and three prospective (two short term and one long term [five years]) clinical studies 
found higher levels of negative life events to be associated with symptom maintenance in 
patients with FAP.23, 24, 57 There is a need for longitudinal research on prognostic factors of 
FAP.  
 
2.3.  Diagnosis 
2.3.1. Development of the Rome Criteria for functional gastrointestinal disorders 
Because there is no diagnostic biological marker for diagnosing FAP, symptom-based, 
diagnostic criteria have been developed as an attempt to classify specific diagnostic entities 
based on typical constellations of gastrointestinal symptoms. Based on gastrointestinal 
symptoms in adults the Manning criteria were presented in 1978.58 The Rome I criteria 
followed in 1992 and have been revised two times (i.e., Rome II and III) since then.59 The 
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international pediatric Rome II criteria (PRC-II) were introduced in 1999 as a first attempt at 
classifying FGIDs in children and adolescents.60 The PRC-II differed from the adult criteria in 
that they were organized according to main symptoms instead of being organ-targeted.60 
Based on evolving research that pointed out the need for refinement and clarification, the 
PRC-III were published in 2006.4 Notable changes were: introduction of new entities (e.g., 
adolescent rumination syndrome), modification of established categories (i.e., abdominal 
migraine, functional constipation and childhood functional abdominal pain), reduction of the 
required duration of symptoms for all disorders except cyclic vomiting and abdominal 
migraine (from three to two months), and reduction of the required number of episodes of 
pain for cyclic vomiting and abdominal migraine (from   3 to  2 episodes in the preceding 
year).4 The PRC-III for FGIDs in children aged 4-18 years are given in the appendix.  
 
Originally, the Rome classification was based on consensus among experts.32 Evolving 
research has to some extent supported the existence of different diagnostic subgroups in 
children (e.g., irritable bowel syndrome, functional dyspepsia, abdominal migraine and 
childhood functional abdominal pain).3 Other subgroups are still classified more or less by 
consensus (e.g., aerophagia). Evidence to support that the Rome criteria are capable of 
differentiating subgroups of FAP is of crucial importance for implementation in clinical 
practice and research. Compared to research on the adult criteria, very little research on the 
ability of the pediatric Rome criteria to capture distinct and clinical meaningful constellations 
of gastrointestinal symptoms in children has been published. Thus, further studies on the 
PRC-III are needed. 
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2.3.2.  A positive symptom-based approach 
Recent clinical guidelines recommend using the symptom-based Rome criteria in making a 
positive diagnosis of FAP. A positive symptom-based diagnostic approach implies an 
“immediate” recognition of the patient’s abdominal symptoms combined with a normal 
physical examination and the absence of alarm symptoms (e.g., blood mixed with stool, 
documented weight loss, unexplained fever, significant vomiting).61, 62 This approach does not 
abolish the need for additional investigations in children. Additional investigations should be 
carefully considered on the basis of the history and physical findings, but are typically not 
necessary for a diagnosis of FAP.61  
 
A positive symptom-based approach in parallel with limited medical investigations is believed 
to reduce unnecessary and harmful investigations, and to convey approval of the legitimacy of 
the patient’s symptoms, reduce fear of serious illness in children and their parents, and 
facilitate a good therapeutic physician-child/parent relationship.62, 63 On the other hand, a 
diagnosis by exclusion approach alone, may lead to unnecessary and potential harmful and 
expensive investigation and increased uncertainty and worries among children and parents. 
Still, for many clinicians and researchers FAP remains a diagnosis of exclusion, and there is 
an ongoing debate of the clinical utility of the Rome criteria and the symptom-based 
approach.62  
 
2.4.  Treatment 
In harmony with the biopsychosocial model, treatment of children with FAP should not only 
alleviate their symptoms of abdominal pain, but also relieve factors that influence illness 
experience and behavior (e.g., somatic and emotional co-morbidity, parental emotional and 
somatic health, fear of serious illness in the child and their parents and other relevant 
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social/environmental factors). Most likely, a multicomponent targeted therapy that matches 
the patient’s symptomatology (severity and nature), functional limitations and the social and 
emotional context of the patients is of importance. Treatment that targets a single mechanism 
is probably not sufficient.  
 
Reflecting the complexity of FAP, a variety of treatments is suggested: Dietary interventions 
(low lactose diets, dietary fiber supplement, lactobacillus supplementation), pharmacological 
treatment (famotidine, pizotifen, peppermint-oil) and psychological interventions (cognitive 
behavioral therapy, family interventions, relaxation, biofeed back, hypnotherapy). However, 
methodological limitations in several of the previous studies have made interpretation of 
results difficult.64-66 Thus, relatively little empiric evidence exists. Interestingly, there seems 
to be some evidence for beneficial effects of psychological treatment strategies (e.g., 
cognitive-behavioral therapy, hypnotherapy) which are developed to change psychological 
processes thought to contribute to pain and disability in children with FAP.64, 67, 68 Moreover, 
it remains unclear whether children classified in different entities according to the Rome 
criteria, are likely to respond differently to treatment.64, 69  
 
3.  AIM AND RESEARCH QUESTIONS     
 
This thesis is based on two cohort studies that included a clinical sample of patients (4-15 
years) in general pediatric outpatient clinics and a population-based sample of adolescents (14 
years). The objective of the thesis was to study diagnostic classification and characteristics in 
children and adolescents with FAP, and further explore predictive- and prognostic factors of 
FAP. The following research questions are addressed in paper 1-4.  
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1) In referred pediatric patients (4-15 years) with non-organic abdominal pain, what is the 
proportion of patients meeting the criteria for one or more diagnoses of  functional 
gastrointestinal disorders according to the PRC-III, what is the distribution of diagnoses, 
and further, what are the reasons for failure to meet these diagnostic criteria (paper 1)? 
 
2) Do fecal calprotectin concentrations vary between subgroups of referred pediatric patient 
(4-15 years)  with FAP classified according to the PRC-III (paper 2) 
 
3)   A.  Do referred pediatric patients with FAP experience more emotional 
           and frequent somatic symptoms compared with school children in a large,  
            population-based reference sample of school children (paper 3)? 
B.  Do emotional and somatic symptoms in pediatric patients (8-15 years) with FAP 
                  and their mothers predict level of abdominal pain and functional disability  
                  measured at a follow-up consultation after 6-9 months (paper 3)? 
                   
4) Do maternal and child emotional symptoms, physical health and negative life events in 
childhood predict self-reported recurrent abdominal pain in adolescents at age 14 years 
(paper 4)? 
 
4.  MATERIAL AND METHODS 
This thesis is based on two cohort studies, the BAMBI study (paper 1–3) and the TOPP study 
(paper 4). BAMBI is an acronym for ”Barn med Magesmerter ved Barnepoliklinikker i 
Sykehuset Innlandet” (i.e., Children with Abdominal pain in Outpatient clinics at Innlandet 
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Hospital Trust), whereas TOPP is an acronym for ”Trivsel og Oppvekst – Barndom og 
Ungdomstid” (i.e., Tracking Opportunities and Problems  – from Childhood through 
Adolescence).70  
 
4.1. The BAMBI study 
4.1.1. Design 
The BAMBI study is a prospective study designed to identify and follow up a representative 
sample of referred pediatric patients (4-15 years) with FAP in four general pediatric outpatient 
clinics (secondary health care) at Innlandet Hospital Trust. The study was conducted from 
February 2006 to April 2008 and included assessment at two time points (i.e., baseline and 
follow-up after 6-9 months). The follow-up consultation was arranged as part of the study. At 
both time points all patients included underwent a consultation by one of the pediatricians and 
questionnaire data were collected from the participants.  
 
Since we also wanted to assess to what extent pediatric patients with FAP differed from 
children in the general population with respect to emotional and somatic symptoms, a 
representative sample of Norwegian school children that participated in a health profile 
survey in 2002 constituted the reference sample (description below).71, 72  
 
4.1.2. Clinical sample and reference sample 
The four outpatient clinics at our hospital are the only pediatric referral clinics serving 
approximately 330,000 inhabitants in the counties of Oppland and Hedmark in Norway, with 
the exception of one pediatrician working part time in a small practice. In Norway, pediatric 
consultations are only accepted based on referrals from general practitioners. Only new 
referrals of Norwegian speaking patients (4-15 years), without abdominal pain of known 
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organic etiology were eligible. Patients with abdominal pain of known organic etiology were 
excluded. The inclusion criterion was chosen to obtain results that are representative for a 
population of children with abdominal pain referred to secondary health care, at least in 
Norway.  
 
Overall, 192 consecutive patients (4-15 years) were referred from general practitioners to the 
outpatients clinics for evaluation of recurrent abdominal pain during the inclusion period. 
Fourteen patients cancelled the appointment because of spontaneous improvement and one 
because of emergency admission. Of the 177 eligible patients evaluated for abdominal pain, 
25 (14%) were excluded (22 due to missing consent from one parent, 2 had recently been 
evaluated by a pediatrician, and 1 did not speak Norwegian), leaving 152 (86%) patients in 
the study (142 with FAP, 10 patients with abdominal pain of organic etiology). These patients 
constituted the sample in paper 1 and 2.  
 
Furthermore, patients old enough (i.e., school grade three to ten) to give self-report and who 
were diagnosed with FAP by the pediatricians were extracted from the above mentioned 
clinical sample of 152 patients. The extracted patients (n = 94) with all their mothers 
constituted the clinical sample in paper 3. Eighty-two (87%) teachers reported on the patients. 
Since the reference sample only encompassed school children in grade three to seven, 
seventeen patients of older age (i.e., grade eight to ten) were excluded from the clinical 
sample in the comparison analyses (thus, leaving 77 patients in the comparison analyses). 
 
The reference sample consisted of 14 000 Norwegian school children (school grade three to 
seven) who participated in a health profile survey undertaken in Akershus County by the 
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Norwegian Health Services Research Centre in 2002 (84% participation rate, mean age [SD] 
= 10.5 [0.01] years, 50% girls ). All the 22 municipalities in the county participated in the 
study. Classes at each school were selected at random to obtain a sample representative of the 
county as a whole. The random selection of classes, the high participation rate and the size of 
the reference sample most likely make this sample of school children a valid comparison 
group.71-73  
 
4.1.3.  Non-participants at baseline, patients lost to follow-up and missing data 
The twenty-five of the 177 (14%) eligible patients who were not included in the BAMBI 
study, did not differ significantly from the participants with respect to age and gender (data 
not shown). Moreover, six of the 94 (6%) patients that constituted the clinical sample in paper 
3 were lost to follow-up. By inspection of baseline data, these children did not appear to 
represent any outliers with respect to the investigated variables compared to the 88 
participants that met for follow-up. At the clinics a member of the research team checked the 
questionnaires for missing answers, and gave the participants opportunity to complete the 
items. Thus, the number of missing answers was small. Missing answers were replaced by the 
mean score for the completed items.74 
 
4.1.4.  Medical assessment of the pediatric patients  
All 152 patients included underwent a consultation by one of several pediatricians at the 
outpatient clinics. In general, each patient met the same pediatrician at both consultations. A 
diagnosis of FAP was based on the pediatrician’s exclusion of organic disease through 
medical history and physical examination according to their usual practice, a set of laboratory 
investigations (including measurement of fecal calprotectin) through a predefined protocol 
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(appendix) and the clinical 6-9 months follow-up to confirm the diagnosis. Results of 
supplementary investigations and reported alarm symptoms (e.g., blood in the stools, 
involuntary weight loss, significant vomiting, chronic severe diarrhea, unexplained fever, a 
family history of inflammatory bowel disease) were registered by reviewing the electronic 
medical records after both consultations. Beyond this no information about medical history or 
physical examination was retrieved from the medical records. Diagnostic procedures and 
results are described in paper 1. 
 
4.1.5.  Classification of  symptoms of  abdominal pain in the  patients  
Child gastrointestinal symptoms were classified by parent report with the Questionnaire on 
Pediatric Gastrointestinal Symptomst – the Rome III version (QPGS-RIII [appendix]) which 
is scored according to the PRC-III (appendix).75 The QPGS-RIII is a structured questionnaire 
and is an adaptation and abbreviation of the original QPGS-Rome II version which has 
undergone preliminary validation.75, 76 The form is recommended for use by parents of 4-18 
year old children. The QPGS-RIII comprises five sections: pain or discomfort in the upper 
abdomen above the umbilicus, pain or discomfort in the lower abdomen around and/or below 
the umbilicus, bowel habits, other gastrointestinal symptoms (nausea and vomiting), and 
impairment (limitation in activities) because of symptoms. 
 
4.1.6.  Measurement of patient and maternal somatic and mental health  
Measurement of variables beyond the medical assessment was based on questionnaire data. 
Although we primarily sought to use validated questionnaires in our study, we also used some 
additional non-validated questions. These are marked in the text below. After an overview of 
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questions and questionnaires used in the BAMBI study is given, a more thorough description 
of the validated questionnaires follows. 
 
Measurement in both the clinical sample and the reference sample 
To enable us to compare the clinical sample with the reference sample in paper 3, mothers of 
the pediatric patients answered identical questions about child somatic and mental health as 
previously answered by parents in the reference sample of school children.71, 72 Somatic 
symptoms in children in both samples were assessed by the following question (not validated): 
“During the last six months, how often has the child had the following complaints?” 
Abdominal pain, headache, back pain, neck/shoulder pain and dizziness were rated from 0 
(“seldom or never”) to 4 (“almost every day”). A criterion of once a week or more often was 
used as a cut-off for dichotomizing each symptom into frequent or infrequent/never somatic 
symptoms. Mental health (i.e., emotional and behavioral problems) in patients and school 
children were measured by the Strengths and Difficulties Questionnaires (SDQ) completed by 
the parents.77  
 
Measurement in the clinical sample 
 
Dependent variables (outcomes): Patient abdominal pain (Abdominal Pain Index [API],78 and 
functional disability (Functional Disability Inventory [FDI]) were reported by self-report. 20, 79 
 
Independent variables (potential predictors):  Patient extraintestinal somatic symptoms 
(Children’s Somatization Inventory [CSI]) were reported by self-report.10 Patient emotional 
symptoms and behavioral problems were reported by mothers and teachers only (Strengths 
and Difficulties Questionnaire [SDQ]).77 The mothers also reported on somatic and emotional 
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symptoms in themselves (Subjective Health Complaints [SHC] and Hopkins Symptom 
Checklist-10 [HSCL-10]).80, 81 82 
 
4.1.7. Description of questionnaires 
The Abdominal Pain Index (API) comprises five items assessing the frequency, duration and 
intensity of the child’s perceived abdominal pain in the previous two weeks.78, 83 Frequency of 
pain, in terms of days, is rated from 0 (“not at all”) to 5 (“every day”), and, in terms of times 
per day, from 0 (“none”) to 5 (“persistent”). Duration of pain episodes is measured from 0 
(“no pain”) to 8 (“most of the day”). Typical and maximum pain intensity is measured on two 
scales ranging from 0 (“no pain”) to 10 (“the most possible pain”). Scores on each item were 
standardized using z scores and were added to produce an overall score. The alpha reliability 
for the API in the clinical sample was 0.82.  
 
The Functional Disability Inventory (FDI) is a 15- item questionnaire assessing perceived 
difficulty in physical and psychosocial functioning in multiple contexts (home, school, social 
activities, sleep) as a result of the child’s physical health in the last two weeks.20, 79 Each item 
is rated from 0 (“no trouble”) to 4 (“impossible”). A total score (0–60) is obtained by 
summarizing the ratings on each item. The FDI has demonstrated reliability and validity in 
previous research.20, 79 The alpha reliability for the FDI in the clinical sample was 0.91. In 
addition, to dichotomize the FDI score, we chose a cut-off point of 10. This cut-off point has 
been used in previous studies to separate children in the low range of functional disability 
from children in the moderate to high range.84, 85 
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The Children’s Somatization Inventory (CSI), short version, assesses the child’s experience of 
18 somatic symptoms (i.e., “headaches,” “abdominal pain,” “pain in arms/legs”) in the last 
two weeks.10  Each item is rated from 0 (“not at all”) to 4 (“a whole lot”). A total score is 
obtained by summarizing the items. The CSI has demonstrated adequate reliability and 
validity.10 The alpha reliability for the CSI in the clinical sample was 0.87. To avoid overlap 
in measurement of abdominal complaints, six items on gastrointestinal symptoms were 
excluded from the CSI. A somatic co-morbidity score (0–48) was created by summarizing the 
ratings the remaining items.   
 
The Strengths and Difficulties Questionnaire (SDQ) is a questionnaire for assessing emotional 
and behavioral problems in children and adolescents (www.sdqinfo.com), consists of 25 items 
rated from 0 (“not true”) to 2 (“certainly true”), and composes five subscales (emotional 
symptoms, conduct problems, hyperactivity, peer problems, and prosocial behavior).77 A total 
difficulties score (0–40) is obtained by summarizing the scores of the first four subscales (0–
10). The instrument has previously been used in epidemiological and clinical research,86, 87 
including studies of children with different chronic illnesses.13, 88-90 The SDQ is a well 
validated screening questionnaire.91-93 The internal reliability and test-retest stability of the 
SDQ has been considered satisfactory, despite modest levels of internal reliability for some of 
the subscales.94, 95 Corresponding previous research, the alpha reliabilities for the SDQ in the 
clinical sample were: 0.79 for the total score, 0.68 for emotional symptom–, 0.45 for conduct 
problem–, 0.79 hyperactivity-inattention problem–, 0.56 for peer problem–, and 0.65 for 
prosocial behavior scale.91, 93 
 
The Hopkins Symptom Checklist (HSCL-10) is a 10-item questionnaire for assessing 
emotional symptoms (i.e., anxiety and depressive symptoms).82 Each item is rated from 1 
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(“not at all”) to 4 (“extremely”). An average score (1–4) is calculated by summarizing each 
item score and dividing by 10. The HSCL-10 has approximately as high sensitivity and 
specificity as the more widely used HSCL-25,96 and correlates at 0.97 with the 25-item 
version.97 The reliability and the validity of the HSCL-25 is well established.82, 96, 97 The alpha 
reliability for the HSCL-10 in the clinical sample was 0.91. 
 
The Subjective Health Complaint Inventory (SHC), previously known as the Ursin Health 
Inventory is a 29 item questionnaire for assessing 29 common health complaints (e.g., 
“headache,” ”back pain,” “stomach pain”) experienced during the last month.80, 81 Each item 
is rated from 0 (“not at all”) to 3 (“severe”). A total score is obtained by summarizing the 
items. The internal reliability and test-retest stability of the SHC has been considered 
satisfactory.98, 99 The alpha reliability for the SHC in the clinical sample was 0.87. To avoid 
overlap in measurement of emotional symptoms, five items on anxiety/depressive symptoms 
were excluded. A somatic symptom score (0–72) was created by summarizing the ratings of 
the remaining 24 items.   
 
4.1.8.  Procedure 
Before start of the BAMBI study, the four questionnaires (Questionnaire on Pediatric 
Gastrointestional Symptoms, Abdominal Pain Index, Children’s Somatization Inventory and 
Functional Disability Inventory) were translated into Norwegian after the following 
procedure: The PhD-candidate made translation drafts. Two physicians with academic 
competency (one psychiatrist and one paediatrician) independently commented the items in 
the drafts. New drafts were made and again discussed with the two physicians. When 
consensus was reached, the final drafts were back-translated into English by another fourth 
person. The person involved in the back-translation was fluent in both languages with English 
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as first language. The back-translated versions were all approved by one of the originators. 
The Strengths and Difficulties Questionnaire and the Hopkins Symptom Checklist are 
previously translated into Norwegian, whereas the Subjective Health Complaints Inventory is 
an instrument of Norwegian origin.80, 81 
 
The Questionnaire on Pediatric Gastrointestional Symptoms (QPGS) was sent by mail to all 
referred children with parents together with the appointment for the first consultation. Parents 
were asked to complete the QPGS at home before the first consultation and bring it to the 
clinic if they wanted to participate in the study. At the clinic, but before the first consultation 
by the pediatrician, patients and parents individually completed the other questionnaires. 
Children completed the forms apart from their parents under assistance by the PhD-candidate 
or a study nurse. Questionnaires to the non-meeting parent were sent home by the spouse or 
by mail and were returned to the clinics by mail in a prepaid return envelope. The parents who 
did not return the questionnaires were given one reminder. When participants agreed, teachers 
were asked to complete a questionnaire and return it by mail. After the first pediatric 
consultation, a study nurse gave the parents detailed oral and written information on the 
procedure for collecting a stool sample for determination of calprotectin concentrations. The 
stool sampling procedure was conducted at home. At the clinic, but before the follow-up 
consultation by the paediatrician, the children reported again on the outcome variables. 
Although data from mothers and fathers were retrieved, only maternal data were used. The 
completeness of maternal data and a wish to reduce the amount of data were the main reasons 
for this choice. 
  
The PhD-candidate was responsible for planning, monitoring and conducting the BAMBI 
study. Two nurses working at the outpatient clinics at Lillehammer, Hamar and Elverum were 
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responsible for inclusion and follow-up of 96 of the 152 patients included in the BAMBI 
study. The PhD-candidate was responsible for inclusion and follow-up of 56 children at the 
clinic at Gjøvik. 
  
4.1.9.  Statistics 
All statistical analyses were conducted by the PhD-candidate under supervision by a 
statistician. The Statistical Package for the Social Sciences (SPSS) version 15.0 was used in 
the statistical analyses. The statistical methods are described in the separate papers. 
 
4.1.10.  Ethics   
The BAMBI study was approved by the Regional Committee on Medical Research Ethics and 
the Norwegian Data Inspectorate. General ethical guidelines for research have been followed.  
Written information about the study was sent by mail to the parents of the referred children 
together with the appointment for the first consultation. A shorter and more “child friendly” 
version was also distributed to children of 12 years or older. Oral information was given by a 
member of the research team at the clinic before the first consultation. Written consent was 
obtained from all parents and children of 12 years or older. Each child was given two tickets 
for the cinema as a token of appreciation.  
 
4.2.   The TOPP study 
4.2.1.  Design  
The TOPP study is an ongoing population-based observational study that has followed a 
cohort of 916 mothers with children from the age of 18 months (1993) until the age of 14 
years (2006). The participants were recruited from child health clinics (preventive health 
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care). The cohort was assessed by questionnaires at six different time points (t1–t6). Child 
self-report was obtained from the age of 12 years (t5).  
 
4.2.2.  Sample 
Routinely, more than 95% of all Norwegian families with children attend a public health 
program during the first four years of the children’s lives. All families attending 19 child 
health clinics in seven municipalities in eastern Norway (Nittedal, Bærum, Halden, 
Fredrikstad, Kåkerøy, Onsøy and Borge) in 1993 for the scheduled 18-month vaccination visit 
were invited to complete a questionnaire (t1). Only maternal data were used in the analyses 
because few fathers participated. Of the 1081 eligible families, 916 mothers (85%) agreed to 
participate.  
 
In paper 4 we chose to focus on data from t1 and t5 versus t6. T5 was especially chosen 
because of the use of child self-report which is considered to be a valid measure for assessing 
pain.100 T1 was chosen to attend to the longest time span from t1 to t6. Furthermore, 
approximately 50% of the participants were lost to follow up from t1 to t6. Therefore, to 
ensure continuity of mothers across time points only participating mothers at t5 with t1 data 
were included in the analyses at t5. A total of 456 adolescents (56% girls) completed the RAP 
questions at the last assessment and were included in the cross-sectional analyses at t6. 
Mothers (at t1 and t5) and children (at t5) with RAP data by adolescent self-report at t6 were 
included in the longitudinal analyses of possible predictors for RAP. Table 1 gives the number 
of participants at each assessment and participants in the longitudinal analyses.  
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Table 1. Number of participating mothers and adolescents, and number of participants 
with endpoint data of RAP at t1and t5 
 
Time 
point 
Children’s 
age 
Mothers,  
n 
 
Adolescents, 
n 
 
Mothers of 
adolescents with 
RAP data at t6, 
n 
Children with 
RAP data at 
t6, n 
t1  18 months 916  436  
t5  12 years 590 546 380a 380 
t6  14 years 478 456   
Abbreviations: RAP, Recurrent Abdominal Pain; t1, t5 and t6, time point 1, 5 and 6.  
aOnly participating mothers at t5 with baseline data were included in the analyses at t5. 
 
4.2.3.  Non-participants, mothers  lost to follow-up and missing data 
In the TOPP study, 165 of the 1081 eligible mothers (15%) did not participate in the study. 
Non-respondents at baseline (t1) did not differ significantly from respondents with respect to 
maternal age, education, employment status, number of children and marital status. Morover, 
as common in many cohort studies, there was a substantial loss of participating mothers from 
t1 to t6. Of 916 mothers included at t1, 436 (48%) mothers with data on adolescent abdominal 
pain at t6 were available for the longitudinal analyses. The non-participating mothers (n = 
480) were significantly younger, less educated and reported more anxiety/depressive 
symptoms than participating mothers. The number of missing answers in the questionnaires 
used in the TOPP study was small. Missing answers were replaced by the mean score for the 
completed items.74  
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4.2.4.  Measurement  
Assessment in the TOPP study is based on questionnaire data only. Although we primarily 
sought to use validated questionnaires, we also used some additional non-validated questions. 
These are marked in the text below. After an overview of questions and questionnaires used in 
the TOPP study is given, a more thorough description of the validated questionnaires follows. 
More details about the non-validated questions are given in paper 4. 
 
Outcome measure 
As outlined in the introduction of this thesis, the vast majority of children and adolescents 
with recurrent abdominal pain (RAP) have FAP (i.e., abdominal pain without demonstrable 
evidence of a pathologic condition). However, since the adolescents in the TOPP study did 
not undergo any medical investigation, we found it more appropriate to use the term RAP 
instead of FAP.  
 
Thus, the outcome measure in paper 4 was self-reported RAP in the adolescents (t6). The 
adolescents answered one main question (not validated): “During the last year, have you had 
abdominal pain [not related to the menstrual period] at least once a month in three consecutive 
months?” (yes/no). Adolescents with a positive answer also answered the following sub-
question (not validated):  “Has the abdominal pain led to: school absenteeism, termination of 
hobbies or activities, taking medication, visiting a doctor or changing the diet?” Each domain 
was rated yes or no. A positive answer in the main question and at least one of the sub-
questions were necessary to fulfil the criteria of RAP. 
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Potential predictors 
The following potential maternal predictors by self-report were assessed: Maternal anxiety 
and depressive symptoms  (Hopkins Symptom Checklist [HSCL], the 25-item version at t1 
and the 10-item version at t5),82, 96 maternal physical health at t1 and t5 (one non-validated 
question: “During the last 12 months, have you experienced problems with your own physical 
health [functional disability, somatic illness]?”) and negative life events experienced by the 
mother in the last year at t1 and t5 (a non-validated checklist of 10 items constructed on the 
basis of established life events lists).101, 102  
 
The following potential child predictors by maternal report were assessed: Child colic at t1, 
symptoms of vomiting/diarrhea/constipation at t1 and t5, abdominal pain at t5 (all measured 
by separate non-validated questions) and child depressive symptoms at t5 (Short Mood and 
Feeling Questionnaire for children and adolescents from 8–18 years, parent version).103 
 
The following potential child predictors by self-report at t5 were assessed: Depressive 
symptoms (Short Mood and Feeling Questionnaire for children and adolescents from 8–18 
years, child version),103 frequent ( 1–3 times per week) abdominal pain, frequent ( 1–3 
times per week) extraintestinal pain (i.e. headache, back pain, limb pain) in the last year (both 
measured by separate non-validated questions), and negative life events in the last year (a non-
validated checklist of 6 items). 
 
Sociodemographic variables measured were child gender, maternal age and education.  
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4.2.5.  Description of questionnaires 
The Hopkins Symptom Checklist exists in a 10-item (HSCL-10) and a 25-item (HSCL-25) 
version for assessing emotional (i.e., anxiety and depressive–) symptoms.82, 96 In the TOPP 
study we used the 25-item version at t1 and the 10-item version at t5. In contrast to the HSCL-
10, the HSCL-25 can be subdivided into categories of anxiety (the 10 first items) and 
depression (the 15 last items). The items “thoughts of ending your life” and “loss of sexual 
interest or pleasure” were excluded from the 25-item version questionnaire at t1 because some 
of the mothers who participated in a pilot project perceived them as offensive. In both 
versions of the questionnaire each item is rated on a scale from 1 (“not at all”) to 4 
(“extremely”). The mean total scores and the two subscale scores on HSCL-25 range from 1–
4, with high scores reflecting higher severity of anxiety/depressive symptoms. To obtain 
sufficient participants in the analyses and in accordance with conventional cut-off points, we 
chose a cut-off point of 1.55 on the HSCL-25 (including the two subscales) and 1.85 on the 
HSCL-10.96, 104 In addition, we made the variable “maternal history of psychological distress” 
to express the number of times (from t1–t5) the mothers reported an HSCL score equal to or 
above the cut-off point. A criterion of one or more times was used as a cut-off for 
dichotomizing this variable. 
 
The Short Mood and Feeling Questionnaire (sMFQ) is a 13-item questionnaire assessing 
depressive symptoms in children and adolescents from 8–18 years.103 The questionnaire exists 
in parallel child and parent versions. Each item is rated on a three-point scale (“not true,” 
“sometimes true” and “true”). The total scores range from 0–26 with high scores reflecting 
higher severity of depressive symptoms. In the present study, one item about poor 
concentration was omitted because of space limitations in the questionnaire. However, we still 
chose to use the conventional cut-off point of eight, which is considered an indicator of 
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depression.103, 105 The MFQ has demonstrated reliability and validity in previous research,105, 
106 has been shown to correlate strongly with the Children’s Depression Inventory (CDI),103 
and has previously been used in both population-based and clinical research.103, 107 The alpha 
reliability for the short MFQ in this study was 0.86. 
 
4.2.6.  Procedure  
All families attending 19 child health clinics in eastern Norway in 1993 for the scheduled 18-
month vaccination visit were invited to complete a questionnaire. Nurses at the health centers 
obtained informed consent from the mothers and administered the collection of data for the 
three first assessments. In the latter assessments, questionnaires were sent by post to the 
families.  
 
The PhD-candidate was not involved in planning and conduction of the TOPP study, but was 
invited to include questions about recurrent abdominal pain (RAP) in the questionnaire used 
at the sixth assessment (t6) and to use the data from the previous assessments (t1-t5). The 
PhD-candidate received a complete data file with raw data ready for analyses. 
 
4.2.7.  Statistics 
All statistical analyses were conducted by the PhD-candidate under supervision by a 
statistician. The Statistical Package for the Social Sciences (SPSS) version 15.0 was used in 
the statistical analyses. The statistical methods are described in the separate papers. 
 
4.2.8.  Ethics 
The TOPP study was approved by the Regional Committee on Medical Research Ethics and 
the Norwegian Data Inspectorate. General ethical guidelines for research have been followed. 
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Informed written consent has been obtained from the participants. Analyses have been 
conducted on anonymous data. 
 
 5.  SUMMARIES OF RESULTS  
Paper 1 Diagnosing pediatric functional abdominal pain in children (4-15 years) according 
to the Rome III criteria: Results from a Norwegian prospective study 
In this study we wanted to determine the proportion of referred pediatric patients with non-
organic abdominal pain meeting the criteria for one or more diagnoses of functional 
gastrointestinal disorders according to the PRC-III, and explore the distribution of diagnoses. 
We also wanted to investigate reasons for failure to meet these diagnostic criteria.   
 
Of 152 consecutively referred patients (4-15 years) with recurrent abdominal pain, 142 (93%) 
patients were diagnosed with FAP, whereas 10 (7%) were diagnosed with an organic 
gastrointestinal disease. Of the 142 patients with FAP (mean age = 9.4 years, 89 [63%] girls), 
124 (87%) met the criteria for at least one specific diagnosis of an FGID. IBS was the most 
common diagnosis (43%), followed by abdominal migraine (23%), aerophagia (15%), 
functional abdominal pain (15%) and functional dyspepsia (10%). Eighty-two (66%) children 
were given one FGID diagnosis, 36 (29%) two, and six (5%) three diagnoses. The most 
frequent combinations were IBS and aerophagia (38% of the children with overlapping 
diagnoses) and IBS and abdominal migraine (33%). Eighteen patients (13%) did not fulfil any 
diagnostic criteria. A pain frequency less than that required (i.e., less than once a week) was 
the dominating cause (83%). 
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Paper 2  Fecal calprotectin concentrations in children with functional gastrointestinal 
disorders diagnosed according to the Pediatric Rome III criteria 
In this study we wanted to determine whether fecal calprotectin concentrations vary between 
four groups of pediatric patients with FAP classified according to the PRC-III. The groups 
were as follows: 1) irritable bowel syndrome (both as the only diagnosis or in combination 
with other diagnoses [n = 61]), 2) childhood functional abdominal pain (n = 22), 3) a mixed 
group of patients with abdominal migraine, functional dyspepsia, aerophagia, functional 
constipation or cyclic vomiting (n = 30), and 4) children with FAP, but unclassified according 
to the PRC-III (n = 18). The groups were also compared with established age-specific 
reference ranges.108 
 
Of the 152 consecutively referred pediatric patients included in the BAMBI study, 136 (126 
FAP, 10 organic) delivered a stool specimen for calprotectin analysis. Of the 126 patients 
with FAP, 113 (90%) had fecal calprotectin levels within normal limits and just slightly 
elevated for the remaining children. Eighty-three of the 126 [66%] patients had concentrations 
below the detection limit of 16 mg/kg, 30 [24%] had levels between 16 and 50, and nine [7%] 
had levels between 50 and 100 mg/kg). Four of the 126 patients (3%) had levels above 100 
mg/kg (1 aerophagia, 1 functional abdominal pain, 1 functional constipation, 1 unclassified 
according to the PRC-III). There were no significant differences in median concentrations 
between the four groups. The median calprotectin concentration of the 27 patients with IBS as 
the only diagnosis was less than 16 (range <16-92) mg/kg and did not differ from that of the 
other groups. Eighteen patients did not fulfil any diagnostic criteria according the PRC-III. 
Their median calprotectin level was less than 16 (range <16-136) mg/kg. 
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Paper 3 Functional abdominal pain in children: Significance of child and maternal somatic 
and mental health on levels of abdominal pain and disability  
In this study we wanted to explore to what extent do consecutively referred pediatric patients 
with FAP experience emotional and more frequent somatic symptoms compared with school 
children in a large, population-based reference sample. We also wanted to investigate the 
prospective value of somatic and mental health in pediatric patients with FAP and their 
mothers for level of abdominal pain and functional disability measured at a follow-up 
consultation after 6-9 months.  
 
The current sample of 94 patients (8-15 years) with mothers was extracted from the original 
clinical sample of 152 patients (4-15 years) included in the BAMBI study. A representative 
sample of 14 000 school children constituted the reference sample. The results showed that 
the patients had significantly more emotional and frequent somatic symptoms (headache [OR, 
9.2; 95% CI, 5.9–14.6], pain in neck/shoulder [OR, 7.2; 95% CI, 4.1–12.5] and back pain 
[OR, 6.6; 95% CI, 3.5–12.6]) when compared with the reference sample. In the multivariate, 
prospective analyses, patient older age and peer problems at baseline predicted more 
abdominal pain at follow-up, whereas patient older age, emotional symptoms, prosocial 
behavior and maternal somatic symptoms predicted disability. 
 
Paper 4 Childhood predictors of recurrent abdominal pain in adolescence: 
A 13-year population-based prospective study 
In this population-based study exploring potential childhood predictor of recurrent abdominal 
pain (RAP) in adolescents (14 years), a total of 456 adolescents (56% girls) completed the 
RAP questions (outcome) at the last assessment. Of these, 58 (13%) met the criteria for RAP, 
and 36 (62%) were girls. 
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By multivariate analyses, the following maternal factors predicted RAP in adolescence: 
maternal psychological distress at children’s age18 months (OR, 2.5; 95% CI, 1.3–4.8) and a 
maternal history of psychological distress at children’s age 12 years (OR, 3.2; 95% CI, 1.7–
6.2). The following child factors measured at age 12 years predicted RAP in adolescence: 
abdominal (OR, 2.5; 95% CI, 1.3–4.9) and extraintestinal pain (OR, 2.3; 95% CI, 1.2–4.4) by 
maternal report, self-reported extraintestinal pain (OR, 2.9; 95% CI, 1.4–5.9) and self-
reported depressive symptoms (OR, 2.4; 95% CI, 1.1–5.1). Maternal physical health problems 
and negative life events, and gastrointestinal symptoms in toddlers however, did not predict 
RAP. None of the sociodemographic factors investigated (child gender, maternal age and 
education) were associated with RAP in adolescence.  
 
6.   DISCUSSION 
6.1.  Discussion of paper 1 
6.1.1.  The ability of the pediatric Rome III criteria to identify subgroups of FGIDs in 
children with FAP 
The results presented in paper 1 add evidence of the ability of the pediatric Rome criteria to 
capture distinct and recognizable constellations of gastrointestinal symptoms in children with 
FAP.3, 75, 109-111 The rate of specific FGID diagnoses obtained with the PRC-III in our study is 
in the upper range (87% versus 55–89%) compared to previous studies conducted in tertiary 
pediatric gastroenterology centers based on the PRC-II, indicating that the PRC-III are at least 
as sensitive as the PRC-II in classifying FGIDs in children.75, 109-111 So far, only one study in 
addition to the BAMBI study, has explored the ability of the PRC-III to classify FGIDs in 
children with FAP.109 Barber et al. compared classification results using the PRC-II and PRC-
III for the pain-related FGIDs (irritable bowel syndrome, functional dyspepsia, abdominal 
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migraine, childhood functional abdominal pain, childhood functional abdominal pain 
syndrome) in a sample of pediatric patients (8-17 years) with FAP in tertiary health care.109 
Although some small differences, which may be due to differences in study population and 
inclusion criteria, the distribution of the pain related PRC-III diagnoses are relatively similar 
to our results (table 2).  
 
Table 2.  Distributions of FGID diagnoses according to Rome II versus Rome III criteria 
reported by different studies a 
FGID diagnoses PRC-II b PRC-III 
Baber et al. 2008c 
PRC-III 
Helgeland et al. 2009 c 
Irritable bowel syndrome  20-45 45 43 
Abdominal migraine 1-6 23 23 
Functional dyspepsia 14-47 15 10 
Childhood functional abdominal pain  0-8 11 15 
Functional abdominal pain syndrome - 6 9 
None 11-35 13 13 
Abbreviations: FGID, functional gastrointestinal disorder; PRC-II, pediatric Rome II criteria; 
PRC-III, pediatric Rome III criteria. 
aDistributions are given in percent 
bWalker et al. 2004,111 Schurman et al. 2005,110 Caplan et al. 2005,75 Baber et al. 2008.109 
cBaber et al. 2008,109 Helgeland et al. 2009112 
 
The proportion of overlapping diagnoses, however, differed notably (34% in our study versus 
14% in the study by Barber et al.).109 With respect to the PRC-II, only two studies have 
reported the total proportion of the diagnoses that overlapped (20% in a study by Caplan et al. 
versus 5% in the study by Barber et al.).75, 109  One explanation for the differences between 
these three studies may be that Barber et al. only reported overlap between the pain-related 
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FGID diagnoses, whereas we (using the PRC-III) and the study by Caplan et al. (using the 
PRC-II) reported overlap between all the pediatric Rome diagnoses. Despite the differences, it 
appears that the PRC-III have become somewhat more inclusive at the expense of a greater 
tendency to overlap. 
 
Although our findings support the ability of the PRC-III to classify subgroups of FGIDs in 
pediatric patients with FAP, it is a question whether the overlap represent co-morbidity (i.e., 
co-occurrence) of distinct subgroups of an FGID or artificial categories. For example, the high 
prevalence of both abdominal migraine and aerophagia in our study must be viewed in 
connection with their significant overlap with irritable bowel syndrome. Episodes of intense 
abdominal pain, increased flatulence and abdominal distension are not only symptoms for 
aerophagia and abdominal migraine, but also common symptoms in patients with irritable 
bowel syndrome.4 Hence, a pertinent question is whether abdominal migraine and aerophagia 
are distinct entities or common symptoms of irritable bowel syndrome. With respect to 
abdominal migraine, some studies support the existence of this diagnostic entity.3, 113, 114 
There is less evidence to support the independent existence of aerophagia.115  Accordingly, 
based on research in adults, it has also been questioned whether some of the subgroups 
defined by the Rome criteria represent distinct disorders or different clinical manifestations of 
a common disorder (i.e., widespread irritation of the gut), at least in some people.116, 117 
Moreover, it has been suggested somewhat different etiology in patients with/without 
overlapping FGIDs (i.e., predominantly psychological versus predominantly biological 
etiology), and, consequently, that patients with overlapping diagnosis may benefit from 
different and more comprehensive treatment strategies (e.g., psychological treatment) than 
patients without (e.g., physiologic treatment).117, 118 Whether this  applies to children with 
FAP needs further exploration. Despite the tendency to overlap found in our study, it is 
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noteworthy that more than two thirds (66%) of the patients meeting a diagnosis according to 
the PRC-III fulfilled the criteria for only one diagnosis. A better understanding of the 
background and the implication of the overlap of symptoms is necessary. 
 
6.1.2. The use of the Rome criteria in diagnostic evaluation of patients with recurrent 
symptoms of abdominal pain 
An important task for clinicians is to identify children having an organic gastrointestinal 
disease. Although our study was not designed to determine the accuracy of the PRC-III to 
discriminate between functional disorders and organic diseases, this aspect deserves some 
attention. It has been claimed that it is somewhat meaningless to discuss the ability of the 
Rome criteria to exclude organic disease since the criteria primarily are designed to classify 
FGIDs which is defined only by exclusion of structural disease.119 However, two recent meta-
analyses on previous symptom-based criteria (e.g., Manning-, Rome I- and Rome II criteria) 
for irritable bowel syndrome in adults conclude that the symptom-based criteria alone are 
only moderately helpful in excluding organic disease.120, 121 This may argue for more 
extensive investigations in patients with recurrent abdominal pain in order to rule out organic 
disease. On the other side, results from previous research indicate that the likelihood of 
organic disease is small in the absence of “red flags” (e.g., unexplained fever, significant 
weight loss, blood in the stool).121 These findings argue against an extensive diagnostic 
investigation in the absence of “red flags” in patient populations with a low prevalence (low 
pretest probability) of organic gastrointestinal. The presence of “red flags”, on the other hand, 
indicates a higher likelihood (higher pretest probability) of organic disease and may therefore 
call for additional diagnostic testing.3, 121  
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The low prevalence of organic gastrointestinal disease in our study (7%) is in harmony with 
previous findings and supports a similar approach as recommended in recent clinical 
guidelines.3, 27 The rather low prevalence of patients with alarm symptoms and abnormal test 
results in our sample may therefore limit the number of patients in need for more extensive 
investigations.  
 
6.1.3.  The utility of the Rome criteria 
The purpose of the Rome criteria is to ”promote clinical recognition and legitimization of the 
FGIDs” and “to develop a scientific understanding of their psychopathological mechanisms to 
achieve optimal treatment”.122 However, a criticism has been that the criteria up to now have 
worked better for research purposes than clinical practice.122 The development of the criteria 
has resulted in standardization of inclusion criteria in clinical studies. This has provided better 
patient homogeneity in the clinical studies and has made comparison of results easier. With 
respect to the clinical utility on the other hand, a recent American study of pediatric 
gastroenterologists reported that although knowledge about the Rome criteria is common, 
incorporation in clinical practice is not.123 A previous Norwegian study revealed that general 
practitioners in Norway did not know or use the Rome II criteria to diagnose FGIDs in 
adults.124 A similar situation for the pediatric version of the criteria would probably have been 
revealed had it been assessed. It is also my impression that the pediatric criteria were not 
incorporated into clinical practice among the pediatricians that participated in our study.   
 
Several factors may prevent the dissemination of the Rome criteria in clinical practice. First, it 
is possible that clinicians do not find the criteria useful because the criteria as yet do not 
identify subgroups that differ in etiology and responsiveness to treatment.64, 69 It is also a 
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question whether the criteria are too detailed and time consuming to use in clinical practice. 
Second, in accordance with the biomedical tradition for understanding any disease, the fact 
that there are no biological markers for FAP may reduce the interest for and knowledge about 
functional disorders. This may in turn affect the clinicians’ willingness to incorporate the 
criteria in their clinical practice. Third, a possible gap between current clinical guidelines and 
education of clinicians may also be a factor that prevents dissemination of the Rome criteria 
in clinical practice.  
 
6.1.4.  In conclusion 
The existing PRC-III seem to represent important steps in the development of knowledge 
towards enhanced understanding of FAP and thereby better management. The ability of the 
PRC-III to classify the patients in our study shows promise for improving diagnosis and 
support the use of the criteria as a diagnostic tool. However, the criteria are still insufficient, 
controversy exists and the criteria do not seem to be implemented in clinical practice.62, 123 In 
the absence of diagnostic markers and as long as the etiology of FAP is unrevealed, it is likely 
that future use of symptom-based criteria, although maybe different from the current version, 
is a reasonable way of diagnosing FAP in patients, when used in combination with patient 
history and physical findings.  
 
6.2.  Discussion of paper 2 
6.2.1. Fecal calprotectin concentrations in pediatric patients with FAP  
In harmony with previous research, the vast majority of the patients in the BAMBI study had 
fecal calprotectin concentrations within the normal range, although differences in sample 
selection (e.g., different definition of FAP, age and study setting) make direct comparison of 
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results somewhat difficult.42-45 Since our study was performed, other studies of children and 
adults that support our findings have been published.39, 125 Only one study published in 2008 
reported moderately elevated fecal calprotectin concentrations in 76 pediatric patients with 
FAP when compared with 46 healthy controls.126  
 
Our results suggest that fecal calprotectin concentrations do not differ between subgroups of 
patients with FAP in the BAMBI study. The majority of patients (66%) had fecal calprotectin 
concentrations below the detection limit of 16 mg/kg and just slightly elevated for the 
remaining. Thus, a possible limitation of the current study is lack of statistical power making 
the study insensitive to small differences between the groups. Furthermore, we did not 
examine histopathologically whether a low grade mucosal inflammation was present in our 
patients or not. Thus, our conclusion in paper 2 (i.e., gastrointestinal inflammation is not a 
significant part of the pathogenesis of FAP) is not appropriate. The role of low grade mucosal 
inflammation as an etiological factor in FAP (e.g., irritable bowel syndrome) is receiving 
considerable attention.38 Although several studies report negative results with respect to fecal 
calprotectin, it is possible that inflammatory cells other than neutrophils play a more 
prominent role in the gastrointestinal mucosal inflammatory processes.33, 127-129 A recent study 
of adults found another inflammatory marker than fecal calprotectin (e.g., human -defensin-
2) to be a better indicator of the inflammatory changes involved in the pathophysiology of 
FAP.39  
 
The utility of fecal calprotectin appears to be more relevant in clinical practice as a diagnostic 
test to differentiate symptoms of FAP from organic gastrointestinal disease. Fecal calprotectin 
has been promoted as an inexpensive, non-invasive marker of inflammatory bowel disease 
among patients with chronic or recurrent gastrointestinal symptoms.43, 130, 131 Accordingly, of 
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all patients included in the BAMBI study, those with a value beyond 100 (six patients) 
underwent gastroscopy and colonoscopy (with exception of one child with a slightly elevated 
value and who recovered from pain before the endoscopies). The two patients diagnosed with 
inflammatory bowel disease in our sample both had markedly elevated fecal calprotectin 
 
6.2.3.  In conclusion 
The vast majority of pediatric patients with FAP have fecal calprotectin concentrations within 
the normal range and the fecal calprotectin concentration do not appear to differ between 
subgroups of patients FAP. It appears that other inflammatory markers than fecal calprotectin 
are better indicators of the inflammatory changes involved in the pathophysiology of FAP. 
 
6.3.  Discussion of paper 3 and 4 
6.3.1. Somatic and emotional co-morbidity in children and adolescent with FAP 
Although our findings of more emotional (i.e., anxiety and depressive) and frequent somatic 
(i.e., headache, back pain, pain in shoulder/neck, dizziness) symptoms in pediatric patients 
with FAP than in school children in the general population echo previous findings, the control 
groups in earlier studies are small and represent selected groups of children (paper 3).9-12 The 
use of the large, representative reference sample and the large differences between the clinical 
sample and the reference sample in paper 3 are therefore noteworthy. The odds ratios and the 
lower border of the confidence intervals clearly support that differences are likely to exist. 
However, the exact differences between the samples must be interpreted with caution because 
inaccurate estimates may have been introduced due to the small clinical sample. Also in the 
TOPP-study (paper4) we found that the majority of adolescents with FAP (i.e., RAP) suffered 
from more somatic co-morbidity than the adolescents without FAP (i.e., RAP). We did not 
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measure emotional symptom in the adolescents, but such symptoms would probably have 
been present had it been assessed.22 A recent population-based study reported 6-year old 
children with FAP to have more somatic (i.e., headache, limb pain) and emotional symptoms 
(i.e., anxiety) than children without FAP.13 Thus, it is likely that somatic and emotional co-
morbidity is a feature of children with FAP in general, and not only a feature of patients 
referred to secondary health care. 
 
6.3.2.  Predictive-  and prognostic factors 
Our findings of maternal psychological distress at children‘s age 18 months and a maternal 
history of psychological distress at children’s age 12 years to predict FAP (i.e., RAP) in the 
adolescents (14 years) in the TOPP study are noteworthy (paper 4). The prospective design 
and the long follow-up period of the TOPP study is a contribution to research literature which 
to date has relied heavily on cross-sectional and retrospective designs to understand FAP. Our 
results correspond to one of very few previous prospective studies that found parental anxiety 
and maternal somatic symptoms in the first year of children’s life to predict FAP in the 
children six years later.34 Thus, maternal psychological distress from early childhood may 
play a role in the development of FAP, though a causal relationship can not be established. 
The lack of a predictive value of maternal physical health in the TOPP study must be 
interpreted with caution. An information bias may exist since maternal physical health was 
only measured by one single question. 
 
Parental somatic and emotional health is also reported to affect the course of FAP in 
children.26 Again, little prospective research has been conducted. Although the BAMBI study 
is prospective in the most minimal form (i.e., short follow-up period and assessment at only 
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two time points), our finding of maternal somatic symptoms to predict functional disability in 
the patients at follow-up adds previous research (paper 3).26  
 
Our findings of extraintestinal somatic and emotional (i.e., depressive) symptoms in 
preadolescent children (e.g., 12 years old) to independently predict FAP (i.e., RAP) two years 
later (paper 4) support that such symptoms in children may play a role in development of 
FAP. The results correspond in part to one population-based prospective study that found 
somatic symptoms other than abdominal pain (i.e., headache) and psychosocial difficulties to 
predict new onset of chronic abdominal pain in adolescents.35 In the TOPP study we did not 
select adolescent with new onset FAP. Therefore, we can not conclude that emotional and 
somatic symptoms are “true” predictors for FAP in our sample.132 Some of the 56 adolescents 
with FAP (i.e., RAP) most likely had symptoms of abdominal pain when they were 12 years 
old.  However, somatic symptoms (e.g., abdominal pain, headache, limb and musculoskeletal 
pain) in children and adolescents are likely to coexist and appear to persist in some 
children.133-136  
 
In the TOPP study, the predictive value of child emotional (i.e., depressive) symptoms at age 
12 years for FAP (i.e., RAP) two years later is also noteworthy (paper 4). Again little 
longitudinal research exists, and interestingly, the association between FAP and 
anxiety/depressive symptoms reported in previous studies has mainly been examined without 
taking the co-morbidity with other somatic symptoms, a possible confounder, into 
consideration. There seems to be an association between somatic and anxiety/depressive 
symptoms in general, not just between FAP and anxiety/depressive symptoms.133, 137, 138 
However, the causal direction of the associations cannot be established from most of these 
studies because of their cross-sectional design.  
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The fact that higher levels of emotional symptoms in the patients in the BAMBI study also 
were found to predict more functional disability at follow-up (paper 3) underscore the 
importance of co-morbid symptoms as prognostic factors.  Previous research has reported 
emotional and somatic co-morbid symptoms to negatively affect the prognosis in children 
with FAP, although little prospective research has been conducted.26, 57 It is possible that 
children with FAP and emotional and somatic co-morbidity are more vulnerable to adopt a 
chronic sick role than children with less co-morbid symptoms. Such an explanation 
corresponds to previous findings of somatic and emotional symptoms, as well as disability to 
be associated with less efficient coping of life stress in this patient group.139-141  
 
The reason why child somatic co-morbidity and maternal emotional symptoms did not predict 
level of abdominal pain or functional disability at follow-up in the BAMBI study is difficult 
to explain, but may be due to methodological limitations, at least partly. Like most previous 
research we explored children with FAP as one group. Thus, variations within the group may 
have been masked.  For example, the mean level of disability was low, despite variations in 
disability within the sample. This may be contributing to the negative findings of significant 
associations between some of the potential baseline predictors and functional disability at 
follow-up. 
 
The associations between parental and child symptoms reflect, as mentioned in the 
background section, both environmental and hereditary influences.36  The relative 
contribution of genetic and environmental factors, however, is still disputed and the results 
from twin studies are conflicting, but there appears to be a strong environmental influence.33, 
37, 142 Social learning and reinforcement of child illness behavior have been suggested as 
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possible mechanisms.36, 143 Parents’ own health, health experiences and cognitions (worries, 
beliefs and fears) may affect their responses to symptoms and illness in them selves and their 
children, thereby affecting their child’s responses to pain.144-146 With respect to genetic 
factors, some studies of twins have reported a genetic influence on development of FAP (i.e., 
irritable bowel syndrome),142, 147-149 but controversy exists.150 The possible heritable 
component and the genetics are poorly understood.37 A genetic disposition can give rise to 
physiological effects, but can also make a child more vulnerable to environmental or social 
factors that in turn affect the gastrointestinal functioning via the brain-gut axis.36 Various gene 
polymorphisms are suggested to be relevant for the pathogenesis of FAP, but more research is 
needed in this field. 33  Previous research has also raised the issue whether there are common 
genetics predispositions for FAP and a vulnerability to anxiety and somatization. 33, 37 
  
Negative life events (NLE) in childhood did not predict FAP (i.e., RAP) in the adolescents in 
the TOPP study (paper 4). Unfortunately, we did not measure NLE in the BAMBI study. 
Thus, we did not have an opportunity to explore NLE as a potential prognostic factor. Prior 
research suggest major NLE to precede onset and exacerbations of symptoms in adult patients 
with FGIDs,151, 152 and NLE are also reported to predict symptom maintenance in both adult 
and child samples.3, 153, 154 However, the experience of life events is influenced by factors such 
as emotional health, illness attitudes, personality traits and coping strategies.19, 36, 155 This 
complicates inferences of associations between NLE and FAP. A possible explanation of the 
negative results in the TOPP study may be the relatively long period between the reported 
NLE and the outcome. Moreover, assessment of life events by questionnaires may not give 
valid information. In general, measures based on interviews are thought to give more valid 
information.48, 156  
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6.3.3.  In conclusion  
Results from the TOPP (paper 4) and the BAMBI (paper 3) study support that somatic and 
emotional symptoms in parents and children may be of importance in development and 
maintenance of FAP in children. Despite some discrepancies and the somewhat scarce 
findings especially in the prospective analyses of data from the BAMBI study, the main 
findings in paper 3 and 4 in general are in harmony with previous research and the prevailing 
understanding of FAP in a biopsychosocial perspective. The discrepancies from previous 
research may in part be due to methodological differences (e.g., differences in sample 
selection and measurement) and lack of statistical power due to the relative small samples in 
both our studies. However, the discrepancies are also likely to reflect the complexity of FAP 
and the intricate relationship between the investigated factors when these are explored in 
multivariable regression models. 
 
7.  METHODOLOGICAL CONSIDERATIONS 
7.1.  Internal validity 
 
The validity of a study can be split into internal and external validity.157 If the internal validity 
of a study is low, the quality of evidence that can be derived from a study is poor.158 The 
internal validity of a study is considered a prerequisite for its external validity. In general, two 
types of error may adversely affect the measurement process and limit the internal validity of 
research results: Random and systematic (i.e., selection bias, information bias and 
confounding) errors. Features in study design, measurement and analysis may give rise to or 
limit such errors.  
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7.1.1. Random error 
Random error is unpredictable variability in measurement arising purely by chance, is always 
present in measurement and can be handled by statistical methods (e.g., p-values, confidence 
intervals).159 The amount of random error is reduced as the sample size enlarges. Hence, 
enlargement of sample size is the most important way to limit random error. The relative 
small sample size in the BAMBI study may have enhanced the inherent random error, 
lowered the precision of measurement (as indicated by vide confidence intervals) and thereby 
opened for type I and II errors. The sample in the TOPP study is fairly large, and the effect of 
random error is somewhat less.   
 
7.1.2. Selection bias 
Factors that influence the selection of participants (how and who we select) and the actual 
participation (who are the respondents/non-respondents at baseline, who are lost to follow-up) 
may give rise to selection error (i.e., systematic differences between respondents and non-
respondents with respect to the investigating variables and confounding factors).157 The 
consecutive recruitment from well described populations and the high baseline participation 
rates in the BAMBI and the TOPP study most likely resulted in a rather non-biased sampling 
of participants. In the TOPP study, non-respondents at baseline (t1) did not differ 
significantly from respondents with respect to maternal age, education, employment status, 
number of children and marital status. In the BAMBI study there was no differences between 
participants and non-participants with respect to age and gender. Unfortunately, we did not 
have data to explore possible differences between participants and non-participants with 
respect to other characteristic.  
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The high participation rate at follow-up (94%) in the BAMBI study limits the possibility of 
selection bias due to attrition. By inspection of baseline data, these children did no represent 
any outliers with respect to the investigated variables compared to the 88 participants. In the 
TOPP study however, there was a substantial loss of participating mothers from t1 to t5. The 
higher levels of psychological distress in mothers lost to follow-up compared to participating 
mothers may have resulted in an underestimation of the observed association between 
maternal psychological distress in childhood and RAP in adolescence. The reduction of the 
sample size also questions the prevalence of RAP found in the TOPP study, though 
corresponding to results from previous research.22 
 
7.1.3. Information bias 
How we collect information about or from study participants may also be erroneous.157  
In the BAMBI study, the diagnoses of organic/non-organic (i.e., FAP) abdominal pain were 
left to the discretion of the pediatricians.Their diagnoses were no subject for further 
validation. Some of the diagnoses may therefore be inaccurate. However, the rather extensive 
primary investigation and the 6-9 months follow-up make it unlikely that significant organic 
disease was missed. This is also supported by previous studies where less than 5% of patients 
diagnosed with recurrent abdominal pain in a tertiary care centre and 3% of patients 
diagnosed with an FGID in a primary care setting developed organic disease during the year 
following the first medical evaluation.27, 160 
 
The extensive reliance on questionnaire data in both our studies is likely to reduce the internal 
validity. Ideally, a combination of several methods (questionnaires, interviews and 
observational data) provide a more “complete picture”.  For example, measures based on 
interviews are thought to give more valid information about negative life events,48, 156 and 
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questionnaire data can not replace more detailed psychiatric assessment.161 The use of non-
validated questions may also have reduced the quality of our data, although we used validated 
instruments and established cut-off points to a large extent. For example, in the TOPP study, 
maternal physical health problems were measured by only one question which is unlikely to 
provide a “correct” measure of such problems. The definition of “physical health problems” is 
also likely to vary between individuals. This may have affected the classification of mothers 
(i.e., mothers with/without physical health problems). Moreover, the arbitrary cut-off for 
dichotomizing the score of negative life events in the TOPP study may also have given rise to 
some degree of misclassification.  
 
In the TOPP study, all baseline (t1) variables were reported by the mothers. Maternal 
characteristics (e.g., emotional and physical illness, personality) and her environmental 
context may have influenced her perceptions of the child.162 However, the fact that the 
outcome variable (FAP in the adolescents) was measured by adolescent self-report most likely 
prevents, to some extent, inflated associations. In the BAMBI study on the other hand, the 
sole reliance on child self-reported abdominal pain, somatic comorbidity and functional 
disability, may have inflated the association between these variables due to shared methods 
variance.  
 
In the BAMBI study, child emotional symptoms were only measured by the mothers and 
teachers. Most previous research suggests that third-part informants (e.g., parents and 
teachers) report lower levels of emotional symptoms than those reported by children, although 
controversy exists.163 Parents and teachers may have limited knowledge about children’s 
emotional state and may underreport emotional symptoms.164 On the other hand, it is possible 
that parents and teachers of children with chronic pain are more aware of the children’s 
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symptoms and problem behavior.165  
 
Finally, in the TOPP study, the recall period was relatively long (i.e., participants had to recall 
past events in the last 12 months). Thus, we cannot exclude an inaccuracy (overestimation or 
underestimation) in their reporting.166 It is also a question whether translation of four  
questionnaires from English into Norwegian introduced some discrepancies between the 
original and the translated versions of the questionnaires.167 A formal validation of the 
Norwegian versions has not been conducted.   
 
7.1.4. Confounding 
The third systematic error that reduces the internal validity of study results is confounding 
which means confusion or mixing of effects.157 When the association between an independent 
and a dependent variable is mixed together with the effect of another variable, which has an 
effect on both the independent and the dependent variable, this other variable is a 
confounder.168 The effect of a confounder can be dealt with by statistical means (e.g., the 
association between the independent and the dependent variables can be explored together 
with possible confounders in a multivariate regression model).169 
 
The investigated associations in the BAMBI and the TOPP studies are vulnerable for a 
possible confounding effect of several unmeasured factors. Examples of possible confounders 
in our studies may be: Paternal health was not measured in the TOPP study and was not 
included in the analyses in the BAMBI study. This factor may have confounded the 
association between maternal somatic symptoms at baseline and disability in the pediatric 
patients at follow-up in the BAMBI study (paper 3), or, in the TOPP study, the association 
between maternal emotional symptoms measured at baseline and FAP (i.e., RAP) in their 
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offspring 13 years later (paper 4). Further, in the BAMBI study, we did not measure negative 
life events which may be a possible confounder of, for example, the association between child 
emotional symptoms at baseline and their functional disability measured at follow-up. A last 
example, child emotional symptoms at baseline (t1) were not recorded in the TOPP study and 
may be a confounder of the observed association between maternal emotional symptoms at 
baseline (t1) and FAP (i.e., RAP) in their offspring 13 years later (t6).  
 
7.2.  External validity  
 
External validity (also called generalizability or representativeness) denotes the extent to 
which the results of a study can be applied to other groups, settings or situations.158 The 
external validity of our results depends primarily on whether the participants in the BAMBI 
and the TOPP study systematically differ from the target populations. However, the external 
validity is not considered relevant if the quality of evidence (internal validity) that can be 
derived from a study is poor.158  
 
7.2.1. The BAMBI study 
The high participation rates (86% at baseline, 94% at follow-up) and the consecutive 
recruitment of patients referred from general to pediatric practice within a well-defined 
geographic area most likely make the results representative for children with sufficient 
abdominal pain referred to secondary health care, at least in Norway. However, the results 
may not be similarly applicable to pediatric patients with other FGIDs than FAP, in other age 
groups, and to children with FAP in the general population. Furthermore, the homogeneous 
ethnicity in the BABI study may also limit the external validity of our results to more 
multiethnic populations. Finally, our results may not be representative for other nations or 
cultures because the tendency to seek medical advice for complaints and referral patterns 
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within the medical community may differ. With respect to the reference sample in the 
BAMBI study (paper 2), the random selection of school classes, the high participation rate 
(84%) and the size of the sample most likely make this sample representative, at least for 
Akershus county.71-73  
 
7.2.2. The TOPP study 
The large proportion (95%) of all Norwegian families with children attending a public health 
program during the first years of the children’s life, the consecutive recruitment of 
participants and the high baseline (t1) participation rate (85%) in the TOPP study enhance the 
external validity of the results. Accordingly, the sample at t1 was found to be representative of 
the diversity of social environments of families with children at age 1-2 years in Norway.170 
On the other hand, the reduction of the sample size during time questions the 
representativeness of the current sample because of a selection bias.  Mothers lost to follow-
up were younger, less educated and reported more emotional symptoms than the participating 
mothers (paper 3). This indicates that the mothers that remained in the study were somewhat 
better functioning than mothers lost to follow-up.  
 
8.  CLINICAL IMPLICATIONS 
8.1. Incorporation of the PRC-III in clinical practice? 
Although the development of the Rome criteria appears to have contributed to an enhanced 
awareness, understanding and legitimization of FAP and the other FGIDs in children, it is my 
impression, as claimed by others, that the criteria still are a better tool for research than 
clinical practice.63, 122  The insufficiency of the criteria should not lead to rejection of the 
criteria or abandonment of the principle of a positive diagnosis, but rather stimulate research 
on the validity and clinical utility of the PRC-III.  
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8.2. Screening of co-morbid symptoms in pediatric patients with FAP  
Since presence of excess co-morbidity in patients with FAP may identify patients with 
somewhat different etiology and may be a marker for a negative course,26, 117, 171 screening of 
such symptoms as part of the standard medical evaluation can be an important guide for 
diagnostic assessment and identification of patients at risk for sustained pain. To what extent 
clinicians systematically recognize and incorporate somatic and emotional comorbidity in 
their evaluation and management of children with FAP is uncertain. A recent study of 
American pediatric gastroenterologists reported that psychological evaluation was included in 
“standard” assessment for only 5% of the pediatric gastroenterologists.123  
 
Identification of excess co-morbidity in children with FAP can also be an important guide for 
choice of treatment. Based on research in adults, excess co-morbidity is suggested to be a 
marker for psychological influences on etiology in patients with irritable bowel syndrome.116-
118, 172 Thus, it may turn out that psychological therapies (e.g., cognitive-behavioral therapy 
and hypnotherapy) or centrally acting drugs are especially beneficial in these patients.118, 173. 
 
8.3. Screening of the patients’ contextual frame  
In general, a family-centred perspective is of importance in treatment of all children. 
Accordingly, results from the TOPP and the BAMBI study underscore that maternal health is 
of importance in children with FAP (paper 2 and 3). Parental somatic and emotional health is 
consistently reported to predict poorer child/adolescent functioning and psychological 
adjustment across a range of chronic health conditions.174 Maternal fear about their child’s 
abdominal pain is also reported to differentiate between consulters versus non-consulters.175 
These findings underscore the importance of a focus that is wider than just on the patient’s 
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symptoms. Parent’s health problems or fears may maintain pain and disability in their child 
and oppose progress in treatment of the child. Thus, addressing such factors may be a key to 
success in treatment of children with chronic and disabling pain. 
 
Identification and treatment of somatic and emotional symptoms in mothers may be another 
implication of our findings. As far as I know, no study has explored the potential beneficial 
effects of treating such symptoms in parents of children with FAP. However, there is some 
evidence that treatment of maternal depression improves children’s psychopathology and 
functioning.176 Thus, improvement of maternal mental health may be a reasonable strategy as 
an adjunct when handling children and adolescents with FAP.  
 
8.4. Management of children FAP – a responsibility of specialist health care? 
Children with chronic, severe and disabling symptoms may need referral to specialist health 
care.  It is, however, my general impression, although somewhat speculative, that many 
pediatricians in specialist health care primarily focus on exclusion of organic disease rather 
than further management of these children. When I worked as a clinician in a child- and 
adolescent psychiatric outpatient clinic five years ago, it was also my impression that there 
were very few children with severe and disabling symptoms of FAP among our patients. 
Although some parents of children without physical findings may resist referrals to mental 
health services, one might speculate as to whether this situation also reflect that children with 
FAP seldom are referred to or accepted for further management in pediatric and mental 
specialist health care, at least in Oppland and Hedmark. According to a traditional and 
biomedical disease-based model, the complexity of FAP (i.e., not being a straight forward 
organic disease or emotional disorder) may lead to that children with FAP do not belong 
neither in pediatric nor psychiatric clinics.  
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The complexity of FAP underscores that children with chronic, severe and disabling 
symptoms belong in both pediatric and mental specialist health care services and that 
interdisciplinary cooperation is necessary. Such cooperation is likely to enhance the focus of 
FAP as a biopsychosocial disorder, open for a broader understanding and exploration of 
factors relevant for maintenance of patient symptoms and disability, and enhance 
accomplishment of a tailored, multi-targeted therapy. This may also help the families to 
accept a diagnosis of FAP, stimulate beneficial coping of the child’s pain, and hopefully 
prevent new consultations, a growing mistrust to the health care system and continuation of 
child illness behavior.  
 
9.  FURTHER RESEARCH  
Despite much research on FAP and the other FGIDs in the last years, there is still more to be 
revealed with respect to etiology, diagnostic assessment and treatment. Compared to abundant 
research in adults, far less research has been performed in children and adolescents. However, 
children are not small adults, and results from research on adults may not be applicable in 
children. Thus, there is a general need for more research in children and adolescents with 
FAP.  
 
There is a need for further studies to elucidate the etiology of pediatric FAP. Research on 
possible pathophysiological mechanisms on a molecular and genetic level may support the 
existence of diagnostic subgroups defined by the existing Rome criteria or identify other 
subgroups of patients, and may also identify targets for treatment (e.g., inflammatory changes 
in some patients with FAP may be targets for anti-inflammatory agents).38 However, it is 
important to focus also beyond the gut. There is a general need to perform longitudinal 
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observational studies to increase the quality of evidence, hitherto mostly based on cross-
sectional studies. Studies that follow a cohort of children with FAP to adulthood may 
contribute with knowledge about the natural course of FAP and the evolution and the nature 
of the observed co-morbidity. Whether different subgroups of FAP as defined by the Rome 
criteria (or by other phenotypic characteristics) differ in course is unknown. The prognostic 
value of childhood FAP needs also further elucidation. Few studies have, for example, 
explored the prognostic value of childhood FAP on development of psychiatric disease in 
adulthood.53  Another area for investigation may be the interplay of parental ill health (both in 
mothers and fathers) and adjustment and functional impairment in children with FAP. 
Enhanced understanding in these areas may lead to a better identification of individuals at risk 
of a negative outcome, and will thereby benefit both diagnostic and treatment.   
 
Further research should also confirm the existence of the diagnostic categories defined by the 
PRC-III. A better understanding of the overlap of different subgroups may lead to refinement 
of the Rome criteria and may facilitate clinical management. In parallel of research on the 
existing criteria, there is a need for future studies to explore the existence of potential other 
subgroups classified according to other symptoms than the symptoms included in the PRC-III 
(e.g., patients with higher/lower levels of co-morbidity). Furthermore, the value of a positive 
symptom-based approach should also be explored. Beneficial effects of such an approach 
have been claimed and a symptom-based approach constitutes a fundament in recent clinical 
guidelines,61, 62 although there is limited evidence to support it.  Finally, the utility of the 
Rome criteria in combination with different alarm features in diagnosing FAP is another area 
for investigation. Other acceptable ways of diagnosing FAP without extensive and expensive 
testing should also be explored. 
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There is a general need for randomized controlled trials of the different treatment strategies 
that have been suggested. Taken the complexity of FAP into consideration, research should 
focus on multicomponent treatment strategies (for example, the effect of education programs 
and parental counselling in combination with different psychological therapies, or 
psychological treatment in combination with medication), but also investigate which 
components actively contribute to improvement. Identification of specific subgroups that 
benefit from specific interventions should also be explored (e.g., whether pediatric patients 
with FAP and high level of co-morbidity are more likely to benefit from cognitive therapy or 
hypnotherapy than those with low level of co-morbidity). Finally, results from the TOPP 
study suggest that maternal emotional symptoms may be a target for intervention. Whether 
children with FAP benefit from interventions directed at such symptoms in mothers is largely 
unexplored. 
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ERRATA 
 
 
Page 7, line 1: “Helgeland H, Flagstad G, Grøtta J, Markestad T, Kristensen H” is corrected to  
”Helgeland H, Flagstad G, Grøtta J, Vandvik PO, Kristensen H, Markestad T” 
 
Page 10, section 2.1, line 3: ”.between 8 and years” is corrected to ”between 8 and 10 years” 
 
Page 31, last sentence on the page: “Table 2 gives…” is corrected to “Table 1 gives…” 
 
Page 32, the heading of the table: “Table 2.” is corrected to “Table 1.” 
 
Page 41, table 2, second column, bottom row: ”32” is corrected to “11-35”, and 
 
Page 41, table 2, footnotes, line 4: “aWalker et al. …” is corrected to “bWalker et al.  …...” 
 
Paper 1, page 314, first column, line 10 from the bottom: “…answer whether…” should read 
“answer whenever…” 
 
Paper 3, Table 3 and 4, first column, line one: “Dependent variables” is corrected to 
“Independent variables” 
 
Paper 4, page 363, table 3, fifth column, line 8: “111” should read “11” patients with RAP. 
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APPENDIX 
The pediatric Rome III criteria for functional gastrointestinal disorders (FGIDs) 
Irritable Bowel Syndrome 
Must include all of the following: 
1. Abdominal discomfort or pain associated with two or 
more of the following at least 25% of the time. 
a. Improved with defecation 
b. Onset associated with a change in frequency of stool 
c. Onset associated with a change in form (appearance) of 
stool 
2. No evidence of an inflammatory, anatomic, metabolic or 
neoplastic process 
Abdominal Migraine 
Must include all of the following: 
1. Paroxysmal episodes of intense, acute periumbilical pain 
that lasts for 1 hour or more 
2. Intervening periods of usual health lasting weeks to 
months 
3. The pain interferes with normal activities 
4. The pain is associated with two or more of the following. 
a. Anorexia 
b. Nausea 
c. Vomiting  
d. Headache 
e. Photophobia 
f. Pallor 
5. No evidence of an inflammatory, anatomic, metabolic or 
neoplastic process 
Aerophagia 
Must include at least two of the following: 
1. Air swallowing 
2. Abdominal distention because of intraluminal air 
3. Repetitive belching and/or increased flatus 
Functional dyspepsia 
Must include all of the following: 
1. Persistent or recurrent pain or discomfort centered in the 
upper abdomen (above the umbilicus) 
2. Not relieved by defecation or associated with the onset of 
a change in stool frequency or stool form (i.e., not IBS) 
3. No evidence of an inflammatory, anatomic, metabolic or 
neoplastic process 
Functional Constipation 
Must include two or more of the following. 
1. Two or fewer defecations per week 
2. At least one episode of fecal incontinence per week 
3. History of retentive posturing or excessive volitional stool 
retention 
4. History of painful or hard bowel movements 
5. Presence of a large fecal mass in the rectum 
6. History of large diameter stools that may obstruct the toilet 
Cyclic Vomiting 
Must include both of the following. 
1. Two or more periods of intense nausea and unremitting 
vomiting or retching lasting hours to days 
2. Return to usual state of health lasting weeks to months 
Adolescent Rumination Syndrome 
Must include all of the following: 
1. Repeated painless regurgitation and rechewing or  
expulsion of food that 
a. begins soon after ingestion of a meal, 
b. does not occur during sleep, and 
c. does not respond to standard treatment for 
gastroesophageal reflux 
2. No retching 
3. No evidence of an inflammatory, anatomic, metabolic or 
neoplastic process 
Functional Abdominal Pain 
Must include all of the following: 
1. Episodic or continuous abdominal pain 
2. Insufficient criteria for other FGIDs 
3. No evidence of an inflammatory, anatomic, metabolic or 
neoplastic process 
Functional Abdominal Pain Syndrome 
Must satisfy criteria for childhood functional abdominal pain 
and have at least 25% of the time and one or more of the 
following: 
1. Some loss of daily functioning 
2. Additional somatic symptoms such as headache, limb pain 
or difficulty sleeping 
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BAMBI-STUDIEN  
LEGENS ROLLE VED FØRSTE KONSULTASJON 
 
(protokoll for barnelegene) 
 
 
 
 
 
 
1. Sjekke at sykepleier har fylt ut skjemaene til Helene Helgeland, inkl. samtykke 
 
2. Sjekke at 3 avføringsprøver er undersøkt for blod (Hemofec) og at urin-stix er avlest 
 
3. Sjekke at veiing, høyde- og blodtrykksmåling er utført 
 
4. Klinisk undersøkelse. 
 
5. Tilleggsundersøkelser: 
 
o Alle barn: Blodprøve: Hb, LPK med differensialtelling, blodplater, kreatinin, 
ALAT, GT, amylase, total IgE og matvarepanel, SR, ferritin, serum-folat, 
cøliakiprøver, hemofec i avføring (3 prøver), urin stix. 
 
o Alle barn:10 ml blod tas på glass med rød kork – serum separeres på 
sykehuset. Serum sendes til Laboratoriet med rekvisisjon, Gjøvik for 
nedfrysing i 70 grader i biobank.  
 
o Ved mistanke om obstipasjon: Røntgen oversikt abdomen (et enkelt bilde) 
 
 
o Én avføringsprøve for undersøkelse av kalprotektin. 
 Familien får med hjem navnet glass til avføring, samt utfylt 
rekvisisjonsskjema til Ullevål og konvolutt for prøvesending til Ullevål.  
 
o Kan gjøres på indikasjon: 
 Dyspepsi av ulcustype: 24 timers pH-registrering i øsofagus, eventuelt 
endoskopi. 
 Andre tilleggsundersøkelser: F.eks. ultralyd- og røntgen-undersøkelser, 
laktosebelastning. 
 
 
6. Sørge for at det settes opp til kontroll om 6 måneder. Prosjektsykepleier har ansvar for 
å koordinere timeavtale mht. tidspunktet.  
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SPØRRESKJEMA OM MAGE-TARM- 
SYMPTOMER HOS BARN 
Roma III versjon (QPGS-RIII) 
 
Tilpasset etter Spørreskjema om pediatriske gastrointestinale symptomer  
(Questionnaire on Pediatric Gastrointestinal Symptoms) 
Walker, Caplan-Dover & Rasquin-Weber 2000, revidert 2006 
 
 
 
Foreldre rapporteringsskjema 
Gjelder barn f.o.m. 4 år  
 
 
 
Veiledning 
Dette spørreskjemaet handler om ditt barns fordøyelsessystem (spiserør, mage, tynntarm og 
tykktarm) og problemer man kan ha med det. Noen av problemene kan gjelde barnet ditt, 
andre ikke.  
 
Forsøk å besvare alle spørsmålene så godt som du kan. Hvis det er umulig for deg å svare på 
et bestemt spørsmål, kan du svare ”Jeg vet ikke” der dette er et alternativ. 
Hvis du har noen spørsmål, vil forskningsmedarbeideren gjerne være til hjelp!  
 
 
Dagens dato:  ………………………                    Barnets fødselsdato: ……………………….. 
       
Barnets kjønn:    (1) Gutt      (2) Pike 
 
Hvem fyller ut skjemaet: 
  
 (1) Mor     (2) Far     (4) Andre; hvem:____________________ 
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Seksjon A: SMERTE OG FØLELSE UBEHAG I ØVRE DEL AV 
MAGEN OVENFOR NAVLEN 
Den stiplede linjen i bildet nedenfor viser et område OVENFOR navlen hvor barn av og til 
har vondt, smerter eller har en følelse av ubehag. Noen ord for disse følelsene er magesmerter, 
kvalme, oppblåsthet, metthetsfølelse eller ikke være sulten etter å ha spist veldig lite.  
 
Ovenfor navlen 
Spørsmålene i denne delen av spørreskjemaet er om magesmerter og følelse av ubehag 
OVENFOR navlen, og som barnet ditt kan ha hatt i løpet av de 2 siste månedene. 
Barn kan ha smerter og følelse av ubehag i mer enn et område av magen. I en annen del av 
dette spørreskjemaet vil du få spørsmål om områdene rundt og nedenfor ditt barns navle. 
1. I de siste2 månedene, hvor ofte hadde barnet smerte eller følelse av ubehag i øvre 
    del av magen ovenfor navlen? 
0.  Aldri 
1.  1-3 ganger i måneden  
2.  1 gang i uken 
3.  Flere ganger i uken 
4.  Hver dag 
Hvis barnet ditt ikke har hatt noe smerter eller følelse av ubehag ovenfor navlen de siste to 
månedene, vær snill å gå direkte til Seksjon B. 
2. Hvilke følgende følelser hadde barnet ditt ovenfor navlen de siste 2 månedene? 
   (Dere kan velge flere alternativer) 
a. Smerte   0.  Nei 1.   Ja  
b. Kvalme   0.  Nei 1.  Ja  
c. Oppblåsthet   0.  Nei 1.  Ja  
d. Metthetsfølelse  0.  Nei 1.  Ja  
e. Ikke være sulten etter 
                å ha spist meget lite 0.  Nei 1.  Ja  
3. I de siste 2 månedene, hvor vondt eller hvor stort ubehag hadde barnet ditt  
    i magen ovenfor navlen? 
1.  Litt 
2.  Noe (mellom litt og mye) 
3.  Mye 
4.  Veldig mye       Jeg vet ikke 
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4. Når barnet ditt hadde smerter eller en følelse av ubehag ovenfor navlen, hvor lenge varte 
det? 
 1.  Mindre enn en time 
 2.  1-2 timer 
 3.  3-4 timer 
 4.  Det meste av dagen 
 5.  Hele tiden 
 
5. Hvor lenge har barnet ditt hatt smerter eller en følelse av ubehag ovenfor navlen? 
 1.  1 måned eller mindre  
 2.  2 måneder 
 3.  3 måneder 
 4.  4-11 måneder 
 5.  1 år eller lengre 
 
Sett RING rundt det tallet du synes passer best til hvert spørsmål nedenfor: 
 
Når barnet ditt hadde 
magesmerter eller følelse av 
ubehag ovenfor navlen, 
i de 2 siste månedene, 
hvor ofte: 
0%  
av tiden 
 
 
 
 
Aldri 
25% 
av tiden 
 
(en firedel 
av tiden) 
 
En gang i 
mellom 
50% 
av tiden 
 
(halvparten 
av tiden) 
 
En god 
del ganger 
75% 
av tiden 
 
(tre firedeler 
av tiden) 
 
Det meste 
av tiden 
100% 
av tiden 
 
 
 
 
Alltid 
 
 
 
 
 
Jeg 
vet 
ikke 
6. Ble smerten eller følelsen av 
    ubehag bedre etter at barnet 
    ditt hadde en avføring? 
0 1 2 3 4 x 
7. Var ditt barns avføring (bæsj)  
    mykere og bløtere eller  
    mer vandig enn vanlig? 
0 1 2 3 4 x 
8. Var ditt barns avføring (bæsj) 
    hardere eller mer klumpet enn 
    vanlig? 
0 1 2 3 4 x 
9. Hadde barnet ditt flere 
    avføringer enn vanlig? 
0 1 2 3 4 x 
10. Hadde barnet ditt færre 
      avføringer enn vanlig? 
0 1 2 3 4 x 
11.Følte barnet ditt seg 
     oppblåst? 
0 1 2 3 4 x 
12.Hadde barnet ditt hodepine? 
 
0 1 2 3 4 x 
13.Hadde barnet ditt  
     vanskeligheter med å sove? 
0 1 2 3 4 x 
14.Hadde barnet ditt smerter i 
     armene, bena eller ryggen? 
0 1 2 3 4 x 
15.Følte barnet ditt seg svimmel 
     eller trodde det skulle 
     besvime? 
0 1 2 3 4 x 
16. Gikk barnet ditt glipp av 
      skolen eller stoppet  
      aktiviteter? 
0 1 2 3 4 x 
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Seksjon B:  MAGEUBEHAG OG MAGESMERTE 
  RUNDT OG NEDENFOR NAVLEN  
Spørsmålene i denne seksjonen er om områdene RUNDT og NEDENFOR ditt barns navle. 
Disse områdene er vist med stiplete linjer i bildene nedenfor. Barn har noen ganger 
mageubehag eller smerter i disse områdene. Mageubehag er noen ganger mildere enn smerter. 
                              
  Rundt navlen   Nedenfor navlen 
1. I de siste 2 månedene, hvor ofte hadde barnet ditt mageubehag eller smerter i området 
    rundt eller nedenfor navlen? 
1.   Aldri 
2.   1-3 ganger i måneden
3.   1 gang i uken 
4.   Flere ganger i uken 
5.   Hver dag 
Hvis barnet ditt ikke har hatt noe mageubehag eller smerte i områdene rundt eller nedenfor 
navlen i de siste 2 månedene, vær snill å gå direkte til Seksjon C. 
2. I de siste 2 månedene, hvor vondt hadde barnet ditt vanligvis i området rundt eller  
    nedenfor navlen? 
1.  Litt 
2.  Noe (mellom litt og mye) 
3.  Mye 
4.  Veldig mye   Jeg vet ikke 
3. Når barnet ditt hadde smerter eller følelse av ubehag rundt eller nedenfor navlen, hvor 
    lenge varte det?     
1.  Mindre enn en time 
2.  1-2 timer 
3.  3-4 timer 
4.  Det meste av dagen 
5.  Hele tiden 
4. Hvor lenge har barnet ditt hatt mageubehag eller smerter rundt eller nedenfor navlen? 
1.  1 måned eller mindre  
2.  2 måneder 
3.  3 måneder 
4.  4-11 måneder 
5.  1 år eller lengre 
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Sett RING rundt det tallet du synes passer best til hvert spørsmål nedenfor: 
 
Når barnet ditt hadde 
magesmerter eller følelse av 
ubehag ovenfor navlen, 
i de 2 siste månedene, 
hvor ofte: 
 
0%  
av tiden 
 
 
 
 
Aldri 
25% 
av tiden 
 
(en firedel 
av tiden) 
 
En gang i 
mellom 
50% 
av tiden 
 
(halvparten 
av tiden) 
 
En god 
del ganger 
75% 
av tiden 
 
(tre firedeler 
av tiden) 
 
Det meste 
av tiden 
100% 
av tiden 
 
 
 
 
Alltid 
 
 
 
 
 
 
Jeg 
vet 
ikke 
5. Ble smerten eller følelsen av 
    ubehag bedre etter at barnet 
    ditt hadde en avføring? 
0 1 2 3 4 x 
6. Var ditt barns avføring (bæsj)  
    mykere og bløtere eller mer 
    vandig enn vanlig? 
0 1 2 3 4 x 
7. Var ditt barns avføring (bæsj) 
    hardere eller mer klumpet enn 
    vanlig? 
0 1 2 3 4 x 
8. Hadde barnet ditt flere 
    avføringer enn vanlig? 
0 1 2 3 4 x 
9. Hadde barnet ditt færre 
      avføringer enn vanlig? 
0 1 2 3 4 x 
10.Følte barnet ditt seg 
     oppblåst i magen? 
0 1 2 3 4 x 
11.Hadde barnet ditt hodepine? 
 
0 1 2 3 4 x 
12.Hadde barnet ditt  
     vanskeligheter med å sove? 
0 1 2 3 4 x 
13.Hadde barnet ditt smerter i 
     armene, bena eller ryggen? 
0 1 2 3 4 x 
14.Følte barnet ditt seg svimmel 
     eller trodde det skulle 
     besvime? 
 
0 1 2 3 4 x 
15. Gikk barnet ditt glipp av 
      skolen eller stoppet  
      aktiviteter? 
0 1 2 3 4 x 
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16. I løpet det siste året, hvor mange ganger hadde barnet ditt en episode med svært sterke 
      smerter rundt navlen som varte 2 timer eller lengre og som fikk barnet ditt til å stoppe 
      alt som han eller hun drev med? 
 
 0.   Aldri (hvis aldri, vær snill å gå til neste seksjon C) 
 1.   1 gang 
 2.   2 ganger 
 3.   3-5 ganger 
 4.   6 eller flere ganger 
 
       
16a. I løpet av en episode med svært sterke smerter, hadde barnet noe av det følgende? 
               
 a. Ingen appetitt     0.   Nei     1.   Ja  
 b. Følelse av kvalme (i magen)  0.   Nei     1    Ja  
 c. Oppkast     0.   Nei     1.   Ja 
 d. Blek (i huden)    0.   Nei     1.   Ja 
 e. Hodepine     0.   Nei     1.   Ja  
f. Lysømfiendtlighet    0.   Nei     1.   Ja 
   (ubehagelig å få lys i øynene)  
 
       
 16b. Mellom episoder med svært sterke smerter, blir barnet ditt igjen like frisk som  
                     det pleier i flere uker eller lenger? 
          
   (0) Nei       
   (1) Ja               
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Seksjon C.   AVFØRING (BÆSJING)  
Denne delen av spørreskjemaet spør om ditt barns avføring (bæsjing). 
 
1. I de siste 2 månedene, hvor ofte hadde barnet ditt avføring vanligvis? 
 1.  2 ganger i uka eller sjeldnere 
 2.  3-6 ganger i uka 
 3.  1 gang om dagen 
 4.  2-3 ganger om dagen 
 5.  Mer enn 3 ganger om dagen    Jeg vet ikke 
 
2. I de siste 2 månedene, hvordan var ditt barns avføring (bæsj) vanligvis? 
 1.  (1) Veldig hard 
 2.  (2) Hard 
 3.  (3) Verken for hard eller for myk  
 4.  (4) Veldig myk eller bløt 
 5.  (5) Vandig (vanntynn) 
6.  (6) Det varierer (hans eller hennes   Jeg vet ikke 
             avføringer er ikke alltid like) 
 
 
2a. Hvis ditt barns avføringer (bæsj) vanligvis var harde, hvor lenge har de vært harde? 
 0.  Mindre enn en måned 
 1.  1 måned 
  2.  2 måneder 
  3.  3 eller flere måneder 
 
3. I de siste 2 månedene, gjorde det vondt når barnet ditt hadde en avføring? 
 0.  Nei 
 1.  Ja        Jeg vet ikke 
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8. I de siste 2 månedene, hadde barnet ditt en bæsj som var så stor at den tettet til toalettet? 
     
 0.  Nei 
 1.  Ja    
 
9. Noen barn holder på avføringen (bæsjen) sin selv når det er et toalett tilgjengelig. De kan 
    gjøre dette ved å stivne i kroppen eller krysse bena sine.  I de 2 siste månedene, hvor ofte 
   prøvde barnet ditt å holde på avføringen (bæsjen) når det var hjemme? 
    
 0.   Aldri 
 1.   1-3 ganger i måneden 
 2.   1 gang i uka 
 3.   Flere ganger i uka 
 4.   Hver dag    
 
10. Har en lege eller sykepleier noen gang undersøkt barnet ditt og sagt at barnet ditt hadde  
      mye avføring innvendig? 
       
 0.  Nei 
 1.  Ja    
 
 
 
 
 
 
 
Sett en RING rundt det tallet du synes passer best til hvert enkelt spørsmål nedenfor:  
 
I de siste 2 månedene, 
hvor ofte: 
0%  
av tiden 
 
 
 
 
 
Aldri 
25%  
av tiden 
 
(en firedel 
av tiden) 
 
 
En gang i 
mellom 
50% 
 av tiden 
 
(halvparten 
av tiden) 
 
 
En god 
del 
ganger 
75%  
av tiden 
 
(tre 
firedeler 
av tiden) 
 
Det 
meste 
av tiden 
100% 
 
 
 
 
 
 
Alltid 
 
 
 
 
 
 
 
Jeg 
vet 
ikke 
4. Måtte barnet ditt skynde seg på do 
    for å bæsje? 
0 1 2 3 4 x 
5. Måtte barnet anstrenge seg (presse 
     hardt) for å få bæsjen ut? 
0 1 2 3 4 x 
6. Hadde barnet ditt slim (hvitt, gullig,  
    trådaktig eller seigt materiale) 
    i avføringen sin?  
0 1 2 3 4 x 
7. Hadde barnet ditt følelsen av ikke  
    å være ferdig etter å ha bæsjet  
    (som om det var mer som ikke ville 
    komme ut) 
0 1 2 3 4 x 
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11. I de siste 2 månedene, hvor ofte var ditt barns undertøy flekket eller skitnet til med 
      bæsj? 
 
 0.  Aldri. Hvis aldri, vær snill å gå til Seksjon D 
 1.  Sjeldnere enn 1 gang i måneden 
 2.  1-3 ganger i måneden 
 3.  1 gang i uka 
 4.  Flere ganger i uka 
 5.  Hver dag  
 
 11a. Når barnet ditt flekket eller skitnet til undertøyet sitt, hvor mye var det flekket  
                   eller skitnet til? 
 
   (1) Undertøyet var flekkete (ingen avføring, kun ”bremsespor”) 
   (2) Liten mengde bæsj i undertøyet (mindre enn en hel bæsj) 
   (3) Stor mengde bæsj i undertøyet (en hel bæsj) 
 
 11b. I hvor lang tid har barnet ditt flekket eller skitnet til undertøyet? 
 
  1.   1 måned eller kortere tid 
  2.   2 måneder 
  3.   3 måneder 
  4.   4-11 måneder 
  5.   1 år eller lengre   
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    Seksjon D.   ANDRE SYMPTOMER 
  
 
 
 
 
5. I LØPET AV DET SISTE ÅRET, hvor mange ganger kastet barnet ditt opp om igjen og om 
    igjen uten å stoppe i 2 timer eller lenger? 
 
 0.   Aldri (Hvis aldri, vær snill å gå til spørsmål nr.6) 
 1.   1 gang 
 2.   2 ganger 
 3.   3 ganger 
 4.   4 eller flere ganger 
 
 
5a. Hvor lenge har barnet ditt hatt episoder med oppkast om igjen og om igjen uten  
       å stoppe? 
  1.   1 måned eller kortere tid 
  2.   2 måneder 
  3.   3 måneder 
  4.   4-11 måneder 
  5.   1 år eller lengre   
 
 5b. Følte barnet ditt vanligvis kvalme når han eller hun kastet opp om igjen og  
       om igjen uten å stoppe? 
  1.   Nei 
  2.   Ja 
  
 
 Sett en RING rundt det tallet du synes passer best til hvert spørsmål nedenfor:  
 
I de siste 2 månedene, 
hvor ofte: 
 
Aldri 1-3 
ganger 
pr. 
måned 
Én 
gang i 
uka 
Flere 
ganger 
i uka 
Hver 
dag 
Jeg 
vet 
ikke 
1. Rapet barnet ditt om igjen og om igjen 
    uten å ville det?  
 
0 1 2 3 4 x 
2. Prompet barnet ditt mye veldig ofte? 
 
0 1 2 3 4 x 
3. Utviklet barnet ditt en tydelig utspilt 
    mage i løpet av dagen (du kunne se at 
    den var utspilt)? 
 
0 1 2 3 4 x 
4. Svelget eller slukte barnet ditt ekstra 
    luft? (Du kan ofte høre en klikkende lyd  
    når barnet ditt svelger ekstra luft) 
0 1 2 3 4 x 
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5c. Var barnet ditt frisk i flere uker eller lengre mellom episodene med oppkast om  
      igjen og  om igjen? 
       
  0.  Nei 
  1.   Ja 
 
6. I de 2 siste månedene, hvor ofte kom mat tilbake opp i ditt barns munn etter at det  
    hadde spist? 
  0.  Aldri (Hvis aldri, vær snill å avslutte spørreskjemaet her) 
  1.  1-3 ganger i måneden 
  2.  1 gang i uka 
  3.  Flere ganger i uka 
  4.  Hver dag 
 
 
6a. Skjer dette vanligvis mindre enn en time etter at barnet ditt spiser? 
        0.  Nei 
        1.   Ja 
 
 
6b. Skjer dette mens barnet ditt sover? 
 
        0.  Nei 
        1.   Ja 
 
   
6c. Føler barnet ditt vanligvis kvalme og kaster opp når dette skjer? 
 
        0.  Nei 
        1.   Ja 
 
 
6d. Gjør det vanligvis vondt når maten kommer tilbake opp i munnen hans/ 
      hennes? 
       
        0.  Nei 
        1.   Ja 
 
 
6e. Hva gjør vanligvis barnet ditt med maten som kommer tilbake opp i  
      munnen hans/hennes? 
 
        0.  Svelger den 
        1.   Spytter den ut 
 
 
 
Tusen takk for hjelpen! 

III
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ABSTRACT  
Objective First, to explore to what extent do consecutively referred pediatric patients with 
FAP experience somatic and emotional symptoms compared to school children in a large, 
population-based reference sample. Second, to investigate the prospective value of somatic 
and mental health in pediatric patients with FAP and their mothers for level of abdominal pain 
and functional disability measured at a follow-up consultation after 6-9 months.  
Methods Ninety-four patients (86% participation rate, mean age 11.1 years, 62% girls) 
reported on abdominal pain, other somatic symptoms and disability. Mothers and teachers 
reported on child emotional and behavioral problems. Maternal somatic and emotional 
symptoms were also assessed. Patient self-reported abdominal pain and disability were 
measured at follow-up (94% participation rate). A representative sample of 14 000 school 
children constituted the reference sample. 
Results Compared with the reference sample, the patients experienced significantly more 
emotional symptoms and more frequent somatic symptoms (headache [OR, 9.2; 95% CI, 5.9–
14.6], pain in neck/shoulder [OR, 7.2; 95% CI, 4.1–12.5] and back pain [OR, 6.6; 95% CI, 
3.5;–12.6]). In the multivariate, prospective analyses, patient older age and peer problems at 
baseline predicted more abdominal pain at follow-up, whereas patient older age, emotional 
symptoms, prosocial behavior and maternal somatic symptoms predicted disability. 
Conclusion Somatic and emotional co-morbidity in general pediatric outpatients with FAP 
were confirmed. The observed associations between child and maternal somatic and mental 
health and pain and disability in pediatric patients highlight the importance of a focus that is 
wider than just the patient’s symptoms of abdominal pain.  
 
Keywords: recurrent abdominal pain, co-morbidity, disability, child, mother, health, 
longitudinal study 
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INTRODUCTION        
Pediatric chronic or recurrent abdominal pain is common, affecting 10–15% of school 
children and accounting for 2–4% of all pediatric office visits.[1,2] The majority of affected 
children have functional abdominal pain (FAP).[3-6] These are chronic or recurrent 
gastrointestinal symptoms that cannot be explained by structural or biochemical 
abnormalities.[7] Some children with FAP experience substantial functional disability due to 
limitations in physical and psychosocial functioning.[8-10] According to a biopsychosocial 
model, a complex relationship exists between child and parental health and pain and disability 
in children with FAP.[11] Results from previous studies, the majority of which have a cross 
sectional design, have shown that many children with FAP and their parents experience more 
emotional and somatic symptoms other than abdominal pain compared to healthy 
controls.[12-16] Co-morbid (i.e., co-occurrence of) emotional and somatic symptoms in these 
children are reported to be associated with pain and disability,[9,10] and parents’ own health 
experiences and cognitions (worries, beliefs and fears) may affect their responses to 
symptoms and illness in them selves and their children, thereby affecting their child’s 
responses to pain.[17-20]  Somatic and emotional symptoms in children with FAP and their 
parents are also reported to negatively influence course of pain and disability in children with 
FAP.  However, few longitudinal studies have been conducted.[3,21,22] 
                                                                                                                                                                       
Although it is well known that children with FAP experience more somatic and emotional 
symptoms than healthy controls, the control groups in earlier studies are small and represent 
selected groups of children. [12-14,16] Comparisons of pediatric patients with FAP with a 
representative sample of children in the general population have, to our knowledge, not been 
performed. Further, since relatively few prospective studies have been conducted, more 
knowledge about the prognostic value of child and parental health is needed. 
 
Functional Abdominal Pain in Children 
 
4 
In the current study we wanted to explore to what extent do referred pediatric patients with 
FAP experience somatic and emotional symptoms compared with school children in a large, 
population-based reference sample. We also wanted to investigate the prospective value of 
somatic and mental health in pediatric patients with FAP and their mothers for level of 
abdominal pain and functional disability measured at a follow-up consultation after 6-9 
months. We expected that patients would report more somatic and emotional symptoms than 
children in the reference sample. We also expected that both patients and maternal somatic 
and emotional symptoms would be associated with level of abdominal pain and disability at 
follow-up. 
 
METHODS 
Design 
The current study is part of a prospective study of consecutively referred pediatric patients 
with FAP at four general pediatric outpatient clinics in Norway. The original study was 
conducted from February 2006 to April 2008 and included assessment at two time points (i.e., 
baseline and follow-up as part of the study after 6-9 months). At both time points all patients 
underwent a consultation by one of the pediatricians and questionnaire data were collected 
from the participants. A representative sample of school children (school grade three to seven) 
constituted the reference sample (description below).  
 
Current clinical sample 
Patients old enough (i.e., above school grade three) to give self-report on abdominal pain and 
disability and who were diagnosed with FAP by the pediatricians were extracted from the 
original clinical sample of 152 patients (4-15 years).[6] The extracted patients (n = 94) with 
mothers constituted the current clinical sample. Since the reference sample only encompassed 
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school children in grade three to seven, seventeen patients of older age (i.e., grade eight to 
ten) were excluded from the current patient sample in the comparison analyses.  
 
Original sample 
Only new referrals of Norwegian speaking patients (4-15 years), without abdominal pain of 
known organic etiology were eligible in the original study. Of 192 referred patients 177 were 
eligible. Of these 25 (14%) were excluded (22 due to missing consent from one parent, 2 had 
recently been evaluated by a pediatrician, and 1 did not speak Norwegian). Of the152 patients 
included (86%), ten (7%) were diagnosed with abdominal pain of organic etiology, whereas 
142 (93%) were diagnosed with FAP.[6]  
 
A diagnosis of FAP was based on the pediatrician’s exclusion of organic disease through 
medical history and physical examination according to their usual practice, a set of laboratory 
investigations through a predefined protocol and the clinical 6-9 months follow-up to confirm 
the diagnosis. Electronic medical records were also reviewed for evidence of organic disease 
after both consultations. Diagnostic procedures and results are previously described.[6]  
 
Reference sample 
The reference sample consisted of 14 000 school children (school grade three to seven) who 
participated in a health profile survey undertaken in Akershus County by the Norwegian 
Health Services Research Centre in 2002 (84% participation rate, mean age [SD] = 10.5 
[0.01] years, 50% girls )[23,24]. All the 22 municipalities in the county participated in the 
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study. Classes at each school were selected at random to obtain a sample that was 
representative of the entire county.[23,24]  
 
The study was approved by the Regional Committee on Medical Research and Ethics and the 
Norwegian Data Inspectorate. 
 
Child variables measured in both the clinical and the reference sample  
Somatic symptoms in children in both samples were assessed by the following question: 
“During the last six months, how often has the child had the following complaints?” 
Abdominal pain, headache, back pain, neck/shoulder pain and dizziness were rated from 0 
(“seldom or never”) to 4 (“almost every day).[23,24]  A criterion of once a week or more 
often was used as a cut-off for dichotomizing each symptom into frequent or infrequent/never 
somatic symptoms. 
 
Mental health (i.e., emotional and behavioral problems) in both samples were measured by 
the Strengths and Difficulties Questionnaires (SDQ) completed by the parents.[25] The SDQ 
consists of 25 items rated from 0 (“not true”) to 2 (“certainly true”), and composes five 
subscales (emotional symptoms, conduct problems, hyperactivity, peer problems, and 
prosocial behavior). A total difficulties score (0–40) is obtained by summarizing the scores of 
the first four subscales (0–10). The instrument has previously been used in epidemiological 
and clinical research.[15,26-28] The SDQ is a well-validated screening questionnaire.[29-31] 
Corresponding previous research, alpha reliabilities in this sample were: 0.79 for the total 
score, 0.68 for emotional symptom–, 0.45 for conduct problem–, 0.79 hyperactivity-
inattention problem–, 0.56 for peer problem–, and 0.65 for prosocial behavior scale.[29,31,32] 
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Variables measured  in the clinical sample 
At baseline, patients and their mothers individually completed questionnaires about child 
somatic and mental health. The mothers also answered questions about their own somatic and 
emotional symptoms. When participants agreed, questionnaires were sent by mail to the 
child’s teacher. At follow-up, the patients again reported on their abdominal pain and 
disability. A member of the research team checked the questionnaires for missing answers, 
and gave the participants opportunity to complete the forms. Thus, the number of missing 
values was small. 
 
Child functional disability was measured by patient self-report on the Functional Disability 
Inventory (FDI).[9,33] The 15- item questionnaire assesses perceived difficulty in physical 
and psychosocial functioning in multiple contexts (home, school, social activities, sleep) as a 
result of the child’s physical health in the last two weeks. Each item is rated from 0 (“no 
trouble”) to 4 (“impossible”). A total score (0–60) is obtained by summarizing the ratings on 
each item. The FDI has demonstrated reliability and validity in previous research.[9,33] Alpha 
reliability in this sample was 0.91. In addition, to dichotomize the FDI score, we chose a cut-
off point of 10. In previous studies this cut-off point has been used to separate children in the 
low range of functional disability from children in the moderate to high range.[34,35] 
 
Child abdominal pain was measured by patient self-report of the Abdominal Pain Index (API) 
which assesses the frequency, duration and intensity of the child’s perceived abdominal pain 
in the previous two weeks.[36] Frequency of pain, in terms of days, is rated from 0 (“not at 
all”) to 5 (“every day”), and, in terms of times per day, from 0 (“none”) to 5 (“persistent”). 
Duration of pain episodes is measured from 0 (“no pain”) to 8 (“most of the day”). Typical 
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and maximum pain intensity is measured on two scales ranging from 0 (“no pain”) to 10 (“the 
most possible pain”). Scores on each item were standardized using z scores and were added to 
produce an overall score. Alpha reliability for the API in this study was 0.82. In addition, the 
mothers also answered one question about how long the child had experienced abdominal 
pain. 
 
Child somatic symptoms were measured by patient self-report on the short version of the 
Children’s Somatization Inventory (CSI) which assesses the child’s experience of 18 somatic 
symptoms (i.e., “headaches,” “feeling low in energy/slowed down,” “pain in arms/legs”) in 
the last two weeks.[13]  Each item is rated from 0 (“not at all”) to 4 (“a whole lot”). A total 
score is obtained by summarizing the items. The CSI has demonstrated adequate reliability 
and validity.[13] Alpha reliability for the CSI total score in the clinical sample was 0.87. To 
avoid overlap in measurement of abdominal complaints, six items on gastrointestinal 
symptoms were excluded from the CSI. A somatic comorbidity score (0–48) was created by 
summarizing the ratings the remaining items.   
Child mental health were measured by the Strengths and Difficulties Questionnaires (SDQ) 
completed by the patients’ mothers and teachers (description above). 
 
Maternal emotional symptoms (anxiety and depressive symptoms) were measured by the 10-
item Hopkins Symptom Checklist (HSCL-10).[37] Each item is rated from 1 (“not at all”) to 4 
(“extremely”). An average score (1–4) is calculated by summarizing each item score and 
dividing by 10. The HSCL-10 has approximately as high sensitivity and specificity as the 
more widely used HSCL-25,[38] and correlates at 0.97 with the 25-item version.[39] The 
reliability and the validity of the HSCL-25 is well established.[37-39] Alpha reliability in this 
sample was 0.91. 
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Maternal somatic symptoms were measured by 24 items selected from the Subjective Health 
Complaint Inventory (SHC), previously known as the Ursin Health Inventory.[40,41] The 
SHC consists of 29 common health complaints (i.e., “headache,” ”back pain,” “stomach 
pain”) experienced during the last month. Each item is rated from 0 (“not at all”) to 3 
(“severe”). A total score is obtained by summarizing the items. The internal reliability and 
test-retest stability of the SHC has been considered satisfactory.[42,43] Alpha reliability for 
the total score in this sample was 0.87. To avoid overlap in measurement of emotional 
symptoms, five items on anxiety/depressive symptoms were excluded. A somatic symptom 
score (0–72) was created by summarizing the ratings of the remaining 24 items.   
 
Sociodemographic factors recorded included child gender and age, and the mother’s highest 
completed education within four categories: (1) elementary school, (2) middle school, (3) 
high school and (4) college or university. 
 
DATA ANALYSIS 
All statistical analyses were performed using SPSS 15.0 for Windows. Missing values in the 
questionnaires were replaced by the mean score for the completed items.[44] Differences 
between the clinical and the population-based samples were analyzed with chi-square- and 
Mann–Whitney U tests. Non-parametric tests for non-normally distributed data were used. 
The comparison analyses were rerun with respect to gender post hoc. To assess the predictive 
value of potential predictors of level of abdominal pain and disability in the pediatric patients, 
the following analyses were used: Linear regression analyses were used to assess bivariate 
associations between potential child and maternal predictors for child abdominal pain and 
functional disability. Multivariate linear regression analyses with backward variable selection 
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were performed to assess associations between the independent variables and the outcome 
variables. Only variables significant at the 20% level (p0.2) in the bivariate analyses were 
included in the multivariate analyses.[45] To avoid child SDQ variables (i.e., emotional and 
behavioral problems) reported by both mothers and teachers being included in the same 
analyses, separate multivariate analyses were performed either with maternal or teacher report 
on these variables included. All multivariate analyses were adjusted for the effect of child 
gender and age. The Wilcoxon paired sample test was applied to analyze changes in levels of 
patient abdominal pain and functional disability from baseline to follow-up. To assess the 
level of agreement between patient emotional symptoms by maternal report and teacher report 
the intra-class correlation coefficient was computed post hoc. A significance level of 5% was 
used throughout, except where otherwise specified.  
 
RESULTS 
Clinical sample  
Of 142 pediatric patients (4-15 years) diagnosed with FAP in the original clinical sample, 56 
children were considered too young to give self-report (i.e., below school grade three). Thus, 
94 patients (mean age = 11.1 years [SD 1.9], 58 [62%] girls) with all their mothers constituted 
the current clinical sample. Eighty-two (87%) teachers reported on symptoms in the patients. 
 
Both parents were Nordic for 89 (95%) of the children. Thirty-four (36%) of the mothers had 
a college or university degree and a further 54 (57%) had completed high school. All 94 
patients had experienced abdominal pain for more than two months, 91 (97%) for more than 
three months and 65 (69%) children for more than one year. Their typical intensity of 
abdominal pain in the last two weeks (item four in the API) was in the medium range on a 
scale ranging from 0 to 10 (mean =  4.3, SD = 2.1). Their level of functional disability (FDI 
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score) was relatively low (mean = 6.9, SD = 7.7, median = 4, range 0-42). Twenty-eight 
patients (30%) had FDI scores in the moderate to high range (FDI score > 10). Table 1 gives 
descriptives of the patients with mothers at baseline. 
 
Clinical sample versus reference sample 
Of the 94 patients, 77 (82%) within the same age range (i.e., grade three to seven) as the 
14 000 children in the reference sample were included in the comparison analyses. The 
proportion of girls was higher in the clinical sample than in the reference sample (62% versus 
50%; OR, 1.6; 95% CI, 1.1–2.5) whereas children’s age and maternal education did not differ 
significantly between the samples. The patients had significantly more frequent somatic 
symptoms (table 2) and higher scores on the SDQ emotional subscale (median=3.0, range 0-
10 versus median=1.0, range 0-10, p<0.001). Scores on the other SDQ subscales did not differ 
significantly between the samples. When gender specific analyses were rerun post hoc, the 
differences between the samples remained (data not shown).  
 
Predictors of abdominal pain and disability in patients at follow-up 
Eighty-eight of the 94 patients met for follow-up (94%). From baseline to follow-up the API 
z-score did not change significantly. The median FDI score was significantly reduced (4.0, 
range 0-42 vs. 2.0, range 0-33, p = 0 .002). The proportion of patients that had FDI scores in 
the moderate to high range (FDI scores > 10) was significantly reduced from 28 patients 
(30%) from baseline to 16 patients (18%) at follow-up (p = 0.013).  
 
In the prospective bivariate analyses, being a child of older age ( = 0.31, p = 0.004) at 
baseline was the only significant factor associated with higher level of abdominal pain at 
follow-up, whereas the following factors were significant at the 20% level (thus, included in 
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the multivariate analyses): being a girl ( = 0.16), having somatic comorbidity ( = 0.19) and 
peer problems ( = 0.19). Table 3 gives results from the bivariate analyses of potential 
predictors for disability at follow-up.  
 
In the prospective multivariate analyses (child SDQ variables by maternal report), children of 
older age ( = 0.28, p = 0.007) and with peer problems ( = 0.21, p = 0.05) at baseline 
remained independent predictors for higher level of abdominal pain at follow-up (adjusted 
R2=0.13), whereas children of older age and having mothers with somatic symptoms 
predicted higher level of disability (table 4). When the two multivariate analyses were rerun 
with child SDQ variables by teacher report included, no other significant predictors for 
abdominal pain scores were found, whereas children with higher scores on emotional 
symptoms ( = 0.29, p = 0.009), prosocial behavior ( = 0.23, p = 0.04) and being of older 
age ( = 0.33, p = 0.003) predicted more patient disability at follow-up (adjusted R2=0.15). 
The intra-class correlation between maternal report and teacher report of child emotional 
symptoms (computed post hoc) was low (ICC=0.29). 
 
DISCUSSION 
Results from the comparison analyses showed that the patients with FAP reported more 
somatic and emotional symptoms than the children in the reference sample. Although these 
results echo previous findings, the control groups in earlier studies are small and represent 
selected groups of children.[12-14,16] The large differences between the samples in our study 
are therefore noteworthy. The odds ratios and the lower border of the confidence intervals 
clearly support that differences are likely to exist, although the differences between the 
samples must be interpreted with caution because inaccurate estimates may have been 
introduced due to the small clinical sample. Previous population-based studies have reported 
more somatic and emotional symptoms in children and adolescents with FAP compared to 
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those without.[15,46,47] Thus, it is likely that somatic and emotional co-morbidity is a feature 
of children with FAP in general, and not only a feature of patients referred to secondary health 
care.  
 
The prospective analyses showed that children with peer problems and of older age at 
baseline had increased risk for higher levels of abdominal pain at follow-up. However, the 
predictive value of peer problems must be interpreted with caution because of the low internal 
reliability of the peer problem score in our study. Nevertheless, lower level of social 
competence is reported to be associated with higher level of abdominal pain in adolescents 
and young adults with FAP, and to negatively affect the relationship between pain and 
disability in girls (cross-sectional data).[8,10] On the other side, peer problems (measured on 
the SDQ) did not predict sustained abdominal pain in a one-year population-based cohort 
study of six-years old children with FAP.[22] With respect to the predictive value of child age 
for level of abdominal pain little research has been published. However, the apparent effect of 
age in our study may be due to an age related reporting bias and not represent actual 
differences in the level of perceived pain. 
 
Child emotional and prosocial behaviour predicted functional disability at follow-up, whereas 
child somatic symptoms did not. Previous studies, the majority of which have a cross-
sectional design, have reported emotional and somatic symptoms to be associated with 
disability in pediatric patients with FAP.[8,9,21] One of few existing prospective studies 
reported somatic and emotional co-morbidity in pediatric patients with FAP in tertiary health 
care to be associated with somatic symptoms and disability five years later.[21] A population-
based one-year cohort study also reported headache and limb pains to predict continued 
abdominal pain and school absenteeism in children with FAP.[22] It is possible that children 
with FAP and emotional and somatic co-morbidity are more vulnerable to adopting a chronic 
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sick role than children with less co-morbid symptoms. Such an explanation is corresponding 
previous findings of somatic and emotional symptoms, as well as disability to be associated 
with less efficient coping of life stress in this patient group. [48-50] The reason why child 
somatic co-morbidity did not predict level of abdominal pain or disability at follow-up may be 
due to, at least partly, the fact that we explored children with FAP as one group. Despite 
variations in disability within the sample, the mean level was low. This may be contributing to 
the null findings of significant associations between some of the potential baseline predictors 
(e.g., patient somatic co-morbid symptoms) and disability at follow-up.The predictive value 
of increasing child prosocial behavior for disability has not been previously reported, is 
somewhat surprising and seems to contradict possible peer problems within these patients. We 
have no convincing explanation for this result.  
 
Only somatic, not emotional symptoms in mothers predicted child disability at follow-up. 
This finding corresponds in part with a previous cross-sectional study that reported maternal 
distress (i.e., both somatic and psychological symptoms) to be associated with disability in 
pediatric patients with FAP or migraine headache.[51] Moreover, a one-year cohort study also 
reported maternal anxiety to predict sustained abdominal pain and school absenteeism in 
children with FAP in the general population.[22] Although, the effect of parental health on 
children’s experience of pain and disability is likely to be mediated through both genetic and 
environmental influences, there appears to be a strong environmental influence.[18] Social 
learning of illness behavior of parents and parental reinforcement of child illness behavior 
have been suggested as possible mechanisms.[18] Parents preoccupation with their own 
somatic or emotional symptoms may influence how their child respond to pain.[17,20,52,53] 
Parental responses such as protectiveness, solicitousness and critical responses are also found 
to increase level of pain and disabilities in children,[17,54] particularly in children with higher 
levels of emotional distress.[54] 
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The finding of that patient level of abdominal pain did not change significantly from baseline 
to follow-up, whereas level of disability did, may seem puzzling. However, chronic pain is 
reported to persist in many children. [15,55]  The majority (69%) of our patients reported 
abdominal pain of more than one year duration. Thus, chronicity of abdominal pain may in 
part explain our finding. The reduction in child disability from baseline to follow-up, 
however, may be an effect of the first pediatric consultation and the offer of a follow-up 
consultation. Although level of abdominal pain remained, it is possible that the patients 
handled their pain in a better way at follow-up.  
 
 
Some strengths of our study are the consecutive recruitment of patients referred from general 
to pediatric practice within a well-defined geographic area, the high participation rate and the 
prospective design. This most likely makes the results representative for referred children 
with FAP in secondary health care, at least in Norway. Further, the importance of the multi-
informant approach is underscored by the finding of child emotional symptoms by teacher 
report only as a predictor for patient disability at follow-up. The low correlation between 
mother and teacher reports of child emotional symptoms corresponds with previous research 
and may, in part, explain our finding. [29,56] Children can behave differently across settings, 
and mothers and teachers can observe child behavior differently.  
 
The following study limitations should be considered. Firstly, results from this study cannot 
be generalized to children with pain conditions other than FAP, or to other age groups, and. 
the results from the comparison analyses cannot be generalized to the oldest patients (i.e., in 
grade eight to 10) in the clinical sample because these patients were excluded from these 
analyses. Second, the relatively small sample size allows type II errors and may lead to 
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inaccurate estimates. Third, we did not control for the fact that multiple regression analyses 
were run. Thus, the problem of false positive results can not be ignored. Fourth, the sole 
reliance on child self-reported abdominal pain, other somatic symptoms and functional 
disability, may bias our findings due to shared methods variance. Fifth, child emotional 
symptoms were only reported by mothers and teachers in our study. Parents and teachers may 
have limited knowledge about children’s emotional symptoms and may underreport them. 
[57] On the other hand, it is possible that parents and teachers of children with chronic pain 
are more aware of the children’s symptoms and problem behavior. [58] Finally, the lacking 
differences between the clinical sample and the reference sample with respect to behavioral 
problems and prosocial behavior must be interpreted with caution because of low internal 
reliabilities of the conduct– and peer problem scale in our study.  
 
Despite some discrepancies from previous research and the relatively scarce findings in the 
prospective analyses it is our impression that the main results are in harmony with previous 
research and the prevailing understanding of FAP in a biopsychosocial perspective.[59] 
Although methodological differences and limitations (e.g., differences in sample selection and 
measurement, lack of statistical power due to the small sample in our study) may in part 
explain the discrepancies from previous research and the relatively scarce prospective 
findings, our results are also likely to reflect the complexity of FAP and the intricate 
relationship between the investigated factors when these are explored in multivariable 
regression models.  
 
CONCLUSION 
This study confirms emotional and somatic co-morbidity in pediatric outpatients with FAP in 
secondary healthcare as underscored by significantly more emotional and frequent symptoms 
than the children in a population-based reference sample. Although prospective in the most 
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minimal form (i.e., short follow-up period and assessment at only two time points), the study 
also contributes with knowledge about the prospective value of child and maternal somatic 
and mental health on pain and disability in pediatric patients with FAP. Since patterns of 
disability and illness behaviour can establish in childhood and may extend into adulthood in 
some people, the findings highlight, in harmony with a biopsychosocial model, the 
importance of a focus that is wider than just the patient’s symptoms of abdominal 
pain.[3,8,11] 
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Table 1: Descriptive statistics for baseline variables in the clinical sample 
Variablesa Mean (SD) 
 or % 
Possible  
range 
Observed 
range 
Child variables 
   
Age (years)  child self-report 
 
11.1 (1.9) 8-15 8-15 
Gender, girls                  child self-report 
 
 62%   
Abdominal pain (API)              child self-report 
  
17.2 (7.6) 0-38 0-31 
Functional Disability (FDI) child self-report 
 
6..9 (7.7)        0-45 0-42 
Somatic comorbidity (CSI)   child self-report 
 
5.7 (5.3) 0-48 0-29 
Emotional symptomsb  maternal report 
   teacher report 
 
Conduct problemsb  maternal report 
   teacher report 
     
Hyperactivity problemsb maternal report 
   teacher report 
    
Peer problemsb  maternal report 
   teacher report 
    
Prosocial behaviorb  maternal report 
   teacher report 
3.2 (2.0) 
2.7 (2.4) 
 
1.3 (1.3) 
0.7 (1.5) 
 
3.0 (2.4) 
2.3 (2.4) 
 
1.5 (1.7) 
1.3 (1.6) 
 
8.3 (1.7) 
7.5 (2.3) 
0-10 
0-10 
 
0-10 
0-10 
 
0-10 
0-10 
 
0-10 
0-10 
 
0-10 
0-10 
0-10 
0-10 
 
0-5 
0-8 
 
0-9 
0-10 
 
0-7 
0-6 
 
1-10 
0-10 
Maternal variables    
Emotional symptoms (HSCL-10) 1.5 (0.6) 1-4 1-4 
Somatic symptoms (SHC)   10.2 (7.5) 0-72 0-33 
Abbreviations: API, Abdominal Pain Index; FDI, Functional Disability Inventory; CSI, Children’s 
Somatization Inventory; HSCL-10, Hopkins Symptom Checklist (10-item version); SHC, Subjective 
Health Complaints. 
aAll variables except age and sex, represent continuous scores.  
bDenotes Strengths and Difficulties Questionnaire subscale. 
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Table 2: The proportions of pediatric patients who had experienced frequent somatic 
symptoms in the last six months compared with school children in a large population-
based sample. 
 
Frequent somatic 
symptoms a 
Pediatric 
patients, n (%) 
School Children, 
n (%)b  
OR 
(95% CI) 
Headache                 No 
   Yes 
Dizziness  No 
   Yes 
Pain neck/shoulder No 
   Yes 
Back pain  No 
   Yes 
38 
39 (51) 
60 
17 (22) 
61 
16 (21) 
66 
11 (14) 
12 800 
1 415 (10) 
13 766 
173 (1) 
13 475 
503 (4) 
13 529 
349(3) 
9.2 (5.9–14.6)* 
 
23.0 (13.2–40.2)* 
 
7.2 (4.1–12.5)* 
 
6.6 (3.5–12.6)* 
 
*p < 0.001 
aDenotes child somatic symptoms at least once a week in the last six months reported by the 
mother. 
bNumber of school children varied slightly in each analyses.  
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Table 3 Results from the bivariate linear regression analyses of potential baseline  
predictors for level of child functional disability at follow-up                                                                         
                                                                                                                                                  
Abbreviations: API, Abdominal Pain Index; CSI, Children’s Somatization Inventory; SDQ, Strengths 
and Difficulties Questionnaire; HSCL, Hopkins Symptom Checklist (10-item version); SHC, 
Subjective Health Complaints 
aby child self-report 
bDenotes Strengths and Difficulties Questionnaire subscale. 
Independent variables measured at baseline B (SE)  Beta t p- value 
Child factors  
Age, years 
Gender 
Abdominal pain (API z score) a 
Somatic comorbidity (CSI score) a 
Emotional symptoms b maternal report 
     teacher report 
Conduct problems b   maternal report 
     teacher report 
 Hyperactivity b  maternal report 
     teacher report 
Peer problems b   maternal report 
     teacher report 
Prosocial behavior b   maternal report 
     teacher report  
Maternal factors 
Maternal education 
Maternal emotional symptom (HCSL score) 
Maternal somatic symptoms (SHC score) 
 
1.06 (0.36) 
0.44 (1.46) 
0.03 (0.88) 
0.24 (0.13) 
0.31 (0.35) 
0.54 (0.30) 
0.87 (0.54) 
-0.53 (0.56) 
0.09 (0.30) 
-0.11 (0.35) 
0.85 (0.42) 
-0.07 (0.46) 
-0.39 (0.42) 
0.48 (0.34) 
 
0.67 (1.22) 
2.38 (1.15) 
0.21 (0.09) 
 
0.30 
0.03 
0.01 
0.19 
0.09 
0.20 
0.17 
-0.11 
0.03 
-0.04 
0.21 
-0.02 
-0.10 
0.16 
 
0.06 
0.22 
0.24 
 
2.94 
0.30 
0.03 
1.81 
0.86 
1.80 
1.61 
-0.95 
0.30 
-0.32 
2.01 
-0.15 
-0.92 
1.41 
 
0.55 
2.06 
2.28 
 
0.004 
0.77 
0.97 
0.08 
0.39 
0.08 
0.11 
0.35 
0.77 
0.75 
0.05 
0.88 
0.36 
0.16 
 
0.59 
0.042 
0.025 
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Table 4:  Results from the multivariate linear regression analysis of potential baseline 
predictors for level of patient functional disability at follow-up                                                   
                                                                                                                                                                               
                    
Adjusted R2 = 0.14 
Abbreviations: CSI, Children’s Somatization Inventory; SDQ, Strengths and Difficulties 
Questionnaire; HSCL, Hopkins Symptom Checklist (10-item version); SHC, Subjective 
Health Complaints 
a
 
 by child self-report 
b
 child SDQ variables by maternal report 
 
 
                                      
 
 
 
 
 
 
 
Independent variables measured at baseline B (SE)  Beta t p- value 
Child age 
Child gender 
Child somatic comorbidity (CSI score) a 
Child conduct problems (SDQ subscale score) b 
Child peer problems (SDQ subscale score) b 
Maternal emotional symptom (HCSL score) 
Maternal somatic symptoms (SHC score) 
0.94 (0.35) 
0.76 (1.44) 
0.13 (0.13) 
-0.24 (0.63) 
0.73 (0.40) 
1.35 (1.38) 
0.18 (0.097) 
0.27 
0.06 
0.11 
-0.05 
0.18 
0.12 
0.21 
2.67 
0.53 
1.03 
-0.39 
1.84 
0.98 
2.05 
0.009 
0.60 
0.31 
0.70 
0.069 
0.33 
0.044 
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